d-alpha tocopherol has been researched along with Acute Confusional Senile Dementia in 283 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (2.47) | 18.7374 |
| 1990's | 48 (16.96) | 18.2507 |
| 2000's | 136 (48.06) | 29.6817 |
| 2010's | 70 (24.73) | 24.3611 |
| 2020's | 22 (7.77) | 2.80 |
| Authors | Studies |
|---|---|
| Anil, B; Gunesacar, G; Halici, Z; Kasap, Z; Koca, M; Sevindik, H; Turkaydin, K; Yerdelen, KO | 1 |
| Dikmen, M; Karaküçük-İyidoğan, A; Karaman, N; Koçyiğit-Kaymakçıoğlu, B; Oruç-Emre, EE; Öztürk, M; Sıcak, Y; Taşkın-Tok, T | 1 |
| He, Y; Liu, W; Mi, J; Sang, Z; Wu, A; Yang, J; Zhou, Y; Zhu, G | 1 |
| Nakatani, Y; Noguchi, N; Shimokawa, N; Takagi, M; Urano, Y | 1 |
| Bastiani, P; Boccardi, V; Brancorsini, S; Bruscoli, S; Cecchetti, R; Febo, M; Mazzon, E; Mecocci, P; Poli, G; Scamosci, M | 1 |
| Ashley, S; Bradburn, S; Murgatroyd, C | 1 |
| Browne, D; Maxwell, AP; McGuinness, B; McKay, GJ; Passmore, P; Silvestri, G; Williams, MA; Woodside, JV | 1 |
| Ahmad Damanhuri, MH; Jaafar, F; Makpol, S; Mohd Yusof, YA; Pahrudin Arrozi, A; Shukri, SNS; Wan Ngah, WZ | 1 |
| Farina, N; Isaac, MGEKN; Llewellyn, D; Tabet, N | 1 |
| Abdallah, IM; Brannen, AD; Elfakhri, KH; Kaddoumi, A | 1 |
| Barnes, LL; Bennett, DA; Honer, WG; Li, H; Morris, MC; Nag, S; Schneider, JA; Tangney, CC | 1 |
| Bechtel, C; Doshanjh, L; Fishman, P; Larsen, D; Luo, Y; Morrell, C; Page, R; Remington, R; Samar, A; Shea, TB; Smyers, K | 1 |
| Endres, K; Grimm, HS; Grimm, MO; Hartmann, T; Haupenthal, VJ; Hundsdörfer, B; Lehmann, J; Mett, J; Stahlmann, CP; Zimmer, VC | 1 |
| Che, R; Dong, L; Liu, J; Ma, W; Wang, W; Xiao, R; Yuan, L | 1 |
| Bechtel, C; Larsen, D; Morrell, C; Page, R; Remington, R; Samar, A; Shea, TB | 1 |
| Farina, N; Isaac, MG; Llewellyn, D; Tabet, N | 1 |
| Boesch-Saadatmandi, C; Frank, J; Gaedicke, S; Gardemann, A; Huebbe, P; Lou, Y; Rimbach, G; Wiswedel, I; Zhang, X | 1 |
| Altieri, I; Menditto, A; Patriarca, M; Semeraro, A | 1 |
| Ito, S; Iwata, N; Jishage, K; Mizusawa, H; Nishida, Y; Ohtsuki, S; Piao, W; Saido, TC; Sasaguri, H; Takahashi, T; Terasaki, T; Tomimitsu, H; Yamada, H; Yamamoto, N; Yanagisawa, K; Yokota, S; Yokota, T | 1 |
| Huebbe, P; Lodge, JK; Rimbach, G | 1 |
| Doran, E; Gillen, DL; Head, E; Lott, IT; Nguyen, VQ; Tournay, A | 1 |
| Berrougui, H; Fulop, T; Khalil, A; Pawelec, G | 1 |
| Aisen, P; Clark, CM; Cotman, C; Cottrell, B; Galasko, DR; Jicha, GA; Montine, TJ; Peskind, E; Quinn, JF; Ringman, JM; Thomas, RG | 1 |
| Chaves, MM; Cintra, MT; de Moraes, EN; de Oliveira, BF; dos Santos, RR; Nogueira-Machado, JA; Veloso, CA | 1 |
| Kurup, PA; Kurup, RK | 1 |
| Maezawa, I; Montine, KS; Montine, TJ; Ou, JJ; Woltjer, RL | 1 |
| Kaye, JA; Montine, KS; Montine, TJ; Moore, M; Morrow, JD; Quinn, JF | 1 |
| Jin, LW; Maeda, N; Maezawa, I; Martin, GM; Montine, KS; Montine, TJ; Woltjer, RL | 1 |
| Aggarwal, NT; Bienias, JL; Evans, DA; Morris, MC; Scherr, PA; Tangney, CC; Wilson, RS | 1 |
| Casarett, DJ; Hirschman, KB; James, BD; Joyce, CM; Karlawish, JH; Xie, SX | 1 |
| Kraemer, K; Lodge, JK; Majewicz, J; Minihane, AM; Proteggente, AR; Rimbach, G; Rota, C | 1 |
| Dmitriev, LF | 2 |
| Boesch-Saadatmandi, C; Eckert, GP; Huebbe, P; Jofre-Monseny, L; Minihane, AM; Müller, WE; Rimbach, G; Schaffer, S | 1 |
| Beisiegel, U; Donarski, N; Kontush, A | 1 |
| Abe, T; Tohgi, H | 1 |
| Dziewas, R; Meuth, SG; Nelke, C; Regner-Nelke, L; Ruck, T; Schroeter, CB; Warnecke, T | 1 |
| Jiang, YL; Jiao, B; Liao, XX; Liu, SH; Liu, XX; Liu, YZ; Shen, L; Wan, MD; Wang, JL; Wu, PF; Xiao, XW; Yang, QJ; Zhang, X | 1 |
| Cao, Z; Deng, Y; Sang, Z; Song, Q; Zhang, L | 1 |
| Abdel-Daim, MM; Abid, A; Akter, R; Appu, AP; Ashraf, GM; Bungau, S; Hassan, SSU; Karthika, C; Rahman, MH; Tagde, P | 1 |
| Kesharwani, P; Naqvi, S; Shukla, R; Singh, A; Tiwari, S; Ujjwal, RR; Verma, RK | 1 |
| Ding, H; Kasselman, LJ; Pinkhasov, A; Reiss, AB | 1 |
| de Souto Barreto, P; Díaz, G; Lengele, L; Soriano, G; Sourdet, S | 1 |
| Bergin, P; Cooke, J; Howard, AN; Mulcahy, R; Nolan, JM; Pope, G; Power, R; Power, T; Prado-Cabrero, A; Roche, W | 1 |
| Liu, T; Xie, X; Zhang, H; Zhou, F | 1 |
| Chia, S; Gabriel, JM; Gilmer, M; Habchi, J; Joshi, P; Limbocker, R; Perni, M; Vendruscolo, M; Yang, X | 1 |
| Araújo Filho, I; Cobucci, RN; da Cunha Germano, BC; de Azevedo, EP; de Morais, LCC; de Paiva Cavalcanti, JRL; do Rego, ACM; Fernandes, ACL; Guzen, FP; Idalina Neta, F; Pinheiro, FI | 1 |
| Browne, D; McGuinness, B; McKay, GJ; Woodside, JV | 1 |
| Chonpathompikunlert, P; Hutamekalin, P; Klaypradit, W; Limpawattana, M; Sroyraya, M; Taksima, T | 1 |
| Mehrabadi, S; Sadr, SS | 1 |
| Abner, EL; Crowley, J; Ding, X; Goodman, P; Kryscio, RJ; Schmitt, FA | 1 |
| Arslan, N; Gezmen-Karadag, M; Icer, MA | 1 |
| Abd El-Fattah, AI; Abu-Elfotuh, K; Ali, AA; Elariny, HA | 1 |
| Abner, EL; Caban-Holt, A; Crowley, J; Darke, AK; Goodman, P; Kryscio, RJ; Lovell, M; Schmitt, FA; Yee, M | 1 |
| Chen, T; Chen, X; Dong, Y; Guan, X; Li, M; Liu, Y; Shu, Y; Xu, L | 1 |
| Bramanti, P; Gugliandolo, A; Mazzon, E | 1 |
| Sanz-Ros, J; Viña, J | 1 |
| Dong, R; Li, J; Yang, Q; Zhang, L; Zhang, Y; Zhao, H | 1 |
| Han, Z; Hu, Y; Jiang, Q; Jin, S; Liu, G; Tian, R; Wang, T; Xu, D; Zhao, Y | 1 |
| Bell, JS; Garcia-Ptacek, S; Hilmer, SN; Tan, EC | 1 |
| McEvoy, CT; McGrattan, AM; McGuinness, B; McKinley, MC; Woodside, JV | 1 |
| Cervera-Ferri, A; Esteve, D; Lloret, A; Monllor, P | 1 |
| Li, J; Wang, W; Wang, X; Zhang, H; Zhang, X | 1 |
| Arosio, B; Bastiani, P; Bertagnoli, L; Boccardi, V; Casati, M; Ciccone, S; Ferri, E; Mansi, M; Mecocci, P; Rossi, PD; Scamosci, M | 1 |
| Arroyo, LM; Asthana, S; Bakshi, RS; Carney, S; Chen, P; Chopra, MP; Craft, S; Cruz, AR; Dysken, MW; Gordon, K; Guarino, PD; Heidebrink, JL; Kowall, NW; Llorente, M; Loreck, DJ; Love, S; Malphurs, J; McCarten, JR; Mintzer, JE; Monnell, KA; Pallaki, M; Prieto, S; Sano, M; Schellenberg, GD; Thielke, S; Tomaska, J; Trapp, G; Turvey, CL; Vatassery, G; Vertrees, JE; Vidal-Cardona, A; Woodman, C | 1 |
| Bryan, J; Crichton, GE; Murphy, KJ | 1 |
| Cecchetti, R; Fratiglioni, L; Hooshmand, B; Kåreholt, I; Kivipelto, M; Laatikainen, T; Mangialasche, F; Mecocci, P; Soininen, H; Solomon, A | 1 |
| Evans, DA; Morris, MC; Rajan, KB | 1 |
| Arroyo, LM; Asthana, S; Bakshi, RS; Chen, P; Chopra, MP; Craft, S; Cruz, AR; Dysken, MW; Gordon, K; Guarino, PD; Heidebrink, JL; Kowall, NW; Llorente, M; Loreck, DJ; Love, S; Malphurs, J; McCarten, JR; Mintzer, JE; Monnell, KA; Pallaki, M; Peduzzi, PN; Prieto, S; Sano, M; Schellenberg, GD; Segal, Y; Thielke, S; Tomaska, J; Trapp, G; Turvey, CL; Vertrees, JE; Vidal-Cardona, A; Woodman, C; Zachariah, S | 1 |
| Ballard, C; Corbett, A | 1 |
| Becatti, M; Cascella, R; Cecchi, C; D'Adamio, G; Evangelisti, E; Fiorillo, C; Goti, A; Liguri, G; Zampagni, M | 1 |
| Barnard, ND; Bush, AI; Ceccarelli, A; Cooper, J; de Jager, CA; Erickson, KI; Fraser, G; Kesler, S; Levin, SM; Lucey, B; Morris, MC; Squitti, R | 1 |
| Hermann, DM | 1 |
| Fuchsberger, T; Giraldo, E; Lloret, A; Viña, J | 1 |
| Eloniemi-Sulkava, U; Jyvakorpi, SK; Kautiainen, H; Pietila, SE; Pitkala, KH; Puranen, TM; Raivio, M; Suominen, M | 1 |
| Aisen, PS; Donohue, MC; Edland, SD; Galasko, D; Moghadam, SH; Petersen, RC; Rissman, RA; Roe, AD; Sano, M; Sun, CK; Thomas, RG | 1 |
| Blesa, R; Bongers, A; Harrison, J; Kamphuis, PJ; Olde Rikkert, MG; Scarpini, E; Scheltens, P; Sijben, J; Vandewoude, MF; Vellas, B; Verhey, FR; von Arnim, CA; Witkamp, R | 1 |
| Baglioni, M; Brancorsini, S; Cecchetti, R; Kivipelto, M; Kussmaul, L; Mangialasche, F; Mecocci, P; Monastero, R; Piobbico, D; Ruggiero, C | 1 |
| La Fata, G; Mohajeri, MH; Weber, P | 1 |
| Cecchetti, R; Croce, MF; Ercolani, S; Mangialasche, F; Mecocci, P; Paolacci, L; Pelini, L; Polidori, MC; Raichi, T; Ruggiero, C | 1 |
| Aebischer, O; Benmachiche, M; Bonjour, T; Carrel, G; Castioni, J; Cosma-Rochat, M; Fournier, J; Gachoud, D; Gagliano, M; Giger, A; Greiser, J; Lamy, O; Méan, M; Mieville, A; Rouiller Larpin, N; Tusgul, S; Voruz, S; Wenger, N | 1 |
| Berressem, D; Eckert, GP; Frank, J; Grewal, R; Hagl, S; Sus, N | 1 |
| Ling, TJ; Liu, RT; Liu, W; Wang, SW; Wang, T; Xu, PX; Yang, SG; Zhang, YX | 1 |
| Shinohara, M; Yamada, M | 1 |
| Basambombo, LL; Carmichael, PH; Côté, S; Laurin, D | 1 |
| Grimm, MO; Hartmann, T; Mett, J | 1 |
| Endres, K; Grimm, HS; Grimm, MO; Hartmann, T; Mett, J; Nelke, C; Regner, L; Schorr, P; Stahlmann, CP; Stoetzel, H; Streidenberger, O; Thiel, A; Volmer, DA; Winkler, J; Zaidan, SR | 1 |
| Abner, EL; Caban-Holt, A; Cooper, G; Ding, X; Jicha, GA; Kryscio, RJ; Schmitt, FA; Turner, J | 1 |
| Isaac, MG; Quinn, R; Tabet, N | 1 |
| Baldeiras, I; Duro, D; Garrucho, MH; Oliveira, CR; Pascoal, R; Proença, MT; Rodrigues, A; Santana, I | 1 |
| Feldman, HH; Hsiung, GY | 1 |
| Barkhof, F; DeCarli, C; Harvey, D; Jack, CR; Petersen, RC; Scheltens, P; Thal, LJ; van Straaten, EC | 1 |
| Praticò, D | 1 |
| Aisen, PS; Ascherio, A; Becerra, LM; Irizarry, MC; Peterson, RC; Raman, R; Schwarzschild, MA; Thomas, RG | 1 |
| Dysken, MW; Kirk, LN; Kuskowski, M | 1 |
| Ansari, MA; Hoda, MN; Ishrat, T; Islam, F; Khan, MB; Parveen, K; Saleem, S; Yousuf, S | 1 |
| Bittner, DM | 1 |
| Allard, J; Bixler, R; Harrison, FE; Li, L; May, JM; McDonald, MP; Usoh, C | 1 |
| Darby, EJ; Doody, RS; Pavlik, VN; Rountree, SD | 1 |
| Brewer, GJ | 1 |
| Aisen, PS; Apostolova, LG; Cummings, JL; Decarli, CS; Green, AE; Harvey, DJ; Hwang, KS; Jack, CR; Petersen, RC; Thal, LJ; Thompson, PM; Toga, AW; Zoumalan, C | 1 |
| Prakasam, A; Ramesh, BN; Rao, KS; Rao, TS; Sambamurti, K | 1 |
| Mousa, SA; Usoro, OB | 1 |
| Fratiglioni, L; Kivipelto, M; Mangialasche, F; Mecocci, P; Palmer, K; Rizzuto, D; Winblad, B | 1 |
| Aisen, PS; Andrieu, S; Bednar, MM; Carrillo, M; Donohue, M; Doody, RS; Dubois, B; Feldman, HH; Grundman, M; Hendrix, SB; Khachaturian, ZS; Petersen, RC; Potter, WZ; Salmon, D; Salmon, E; Sampaio, C; Schindler, RJ; Schneider, LS; Siemers, E; Thomas, RG; Touchon, J; Vellas, B | 1 |
| Kong, YK; Lu, CZ; Ni, J; Sun, Y; Yao, LC | 1 |
| Ahmed, HH | 1 |
| Bossù, P; Caltagirone, C; Gianni, W; Iuliano, L; Monticolo, R; Spalletta, G; Spoletini, I; Straface, G | 1 |
| Guan, JZ; Guan, WP; Maeda, T; Makino, N | 1 |
| Aisen, PS; Cummings, J; Schneider, LS | 1 |
| Baldeiras, I; Cardoso, S; Carvalho, C; Correia, SC; Moreira, PI; Oliveira, CR; Santos, MS; Santos, RX | 1 |
| Ji, HF; Li, FJ; Shen, L | 1 |
| Arlt, S; Beisiegel, U; Kontush, A; Müller-Thomsen, T | 1 |
| Akaike, A; Irie, K; Izumi, Y; Izuo, N; Kume, T; Murakami, K; Sato, M | 1 |
| Clark, AR; Farina, N; Isaac, MG; Rusted, J; Tabet, N | 1 |
| Abner, EL; Caban-Holt, A; Crowley, JJ; Dennis, BC; Kryscio, RJ; Mathews, MJ; Mendiondo, MS; Schmitt, FA | 1 |
| Abner, EL; Caban-Holt, A; Crowley, JJ; Dennis, BC; Goodman, PJ; Klein, EA; Kryscio, RJ; Mathews, M; Mendiondo, M; Schmitt, FA | 1 |
| Baglioni, M; Cecchetti, R; Floridi, P; Gobbi, G; Kivipelto, M; Kłoszewska, I; Lovestone, S; Mangialasche, F; Mecocci, P; Muehlboeck, JS; Simmons, A; Soininen, H; Spenger, C; Tarducci, R; Tsolaki, M; Vellas, B; Wahlund, LO; Westman, E | 1 |
| Delaney, P; Grundman, M | 1 |
| Butterfield, DA; Calabrese, V; Castegna, A; Drake, J; Scapagnini, G | 1 |
| Hake, AM | 1 |
| Bonnefoy, M; Drai, J; Kostka, T | 1 |
| Spector, R; Vesell, ES | 1 |
| Bednarska-Makaruk, M; Graban, A; Kunicki, PK; Lojkowska, W; Rodo, M; Ryglewicz, D; Wehr, H | 1 |
| Brenner, S | 1 |
| Varner, AE | 1 |
| Foley, DJ; Launer, LJ; Laurin, D; Masaki, KH; White, LR | 2 |
| Allain, H; Belliard, S; Bentue-Ferrer, D; Djemaï, M; Merienne, M; Reymann, JM | 1 |
| Luchsinger, JA; Mayeux, R; Shea, S; Tang, MX | 1 |
| Martin, A | 1 |
| Gruys, E; Rofina, J; Schwippelova, Z; Skoumalova, A; Wilhelm, J | 1 |
| Catani, M; Cecchetti, R; Cherubini, A; Mariani, E; Mattioli, P; Mecocci, P; Metastasio, A; Polidori, MC; Rinaldi, P; Senin, U | 1 |
| Sano, M | 1 |
| Peskin, ER; Pfeiffer, EA; Porsteinsson, AP; Schneider, LS | 1 |
| Butler, R; Prabhakaran, P; Warner, J | 1 |
| DeLaGarza, VW | 2 |
| Coll, PP; Fortinsky, RH; Kaplan, R; Song, C | 1 |
| Hatakeyama, Y; Nakano, N; Yoshida, T | 1 |
| Lee, VM; Praticò, D; Sung, S; Trojanowski, JQ; Uryu, K; Yang, H; Yao, Y | 1 |
| Cardoso, SM; Oliveira, CR; Proença, MT; Santana, I; Santos, S | 1 |
| Adelman, EE; Karlawish, JH | 1 |
| Anthony, JC; Breitner, JC; Gustafson, D; Khachaturian, AS; Norton, MC; Stone, SV; Tschanz, JT; Welsh-Bohmer, KA; Zandi, PP | 1 |
| Charlton, KE; Dhansay, MA; Geffen, LN; Rabinowitz, TL | 1 |
| Kitamura, S | 1 |
| Kuroiwa, Y; Suzuki, Y | 1 |
| Audivert, S; Boada, M; Burgos, R; Chacón, P; Conde, M; Pérez-Portabella, C; Planas, M; Rossello, J; Tàrraga, LL | 1 |
| Mecocci, P | 1 |
| Funk, CD; Lawson, JA; Lee, VM; Praticò, D; Trojanowski, JQ; Uryu, K; Yao, Y; Zhukareva, V | 1 |
| Ayasolla, K; Khan, M; Singh, AK; Singh, I | 1 |
| Khan, HM; Saeed, M | 1 |
| Shen, ZX | 1 |
| Gupta, S | 1 |
| Hébert, R; Herrmann, N; Luong, D; McCracken, P; Robillard, A; Sambrook, R; Yu, A | 1 |
| Breteler, MM; Engelhart, MJ; Hofman, A; Kiliaan, A; Meijer, J; Ruitenberg, A; van Swieten, JC; Witteman, JC | 1 |
| Arya, P; Butler, R; Warner, J | 1 |
| Coma, M; Muñoz, FJ; Solé, M | 1 |
| Kontush, K; Schekatolina, S | 1 |
| Bennett, D; Doody, R; Ferris, S; Galasko, D; Grundman, M; Jin, S; Kaye, J; Levey, A; Petersen, RC; Pfeiffer, E; Sano, M; Thal, LJ; Thomas, RG; van Dyck, CH | 1 |
| Blacker, D | 1 |
| Gu, R; Guan, ZZ; Liu, RY; Qi, XL; Shan, KR; Xiao, Y; Xiu, J | 1 |
| Cashman, KD; Salerno-Kennedy, R | 1 |
| Appollonio, I; Facheris, M; Ferrarese, C; Galbusera, C; Galimberti, G; Galli-Kienle, M; Guerini, FR; Isella, V; Magni, F; Sala, G; Tremolada, L | 1 |
| Townsend, DM; Tucker, JM | 1 |
| Kumar, R; Nicolosi, RJ; Ortiz, D; Shea, TB; Watterson, AC | 1 |
| Barnes, DE; Yaffe, K | 1 |
| Artz, MB; Dysken, MW; Fillenbaum, GG; Gray, SL; Hanlon, JT; Kuchibhatla, MN; Pieper, CF; Schmader, KE | 1 |
| Boothby, LA; Doering, PL | 1 |
| O'Neill, MF | 1 |
| Cartier, L; Dubois-Dauphin, M; Krause, KH; Li, B; Qin, B; Serrander, L | 1 |
| Pham, DQ; Plakogiannis, R | 1 |
| Jelic, V; Kivipelto, M; Winblad, B | 1 |
| Artero, S; Cristol, JP; Dupuy, AM; Mas, E; Portet, F; Ritchie, K; Touchon, J | 1 |
| Landmark, K | 1 |
| Bucciarelli, T; Ciabattoni, G; Davì, G; Del Re, L; Di Febbo, C; Di Iorio, A; Falco, A; Giusti, C; Paganelli, R; Patrono, C; Pescara, L; Porreca, E; Sau, A | 1 |
| Ownby, RL | 1 |
| Tariot, PN | 1 |
| Castellani, RJ; Moreira, PI; Nunomura, A; Perry, G; Smith, MA; Zhu, X | 1 |
| Canu, E; Frisoni, GB; Geroldi, C; Zacchi, V; Zanetti, O | 1 |
| Bacskai, BJ; Dodwell, SA; Garcia-Alloza, M; Hyman, BT; Meyer-Luehmann, M | 1 |
| Dias-Santagata, D; Duttaroy, A; Feany, MB; Fulga, TA | 1 |
| Fleisher, AS; Gamst, AC; Petersen, RC; Sowell, BB; Taylor, C; Thal, LJ | 1 |
| Ames, D; Ritchie, C | 1 |
| Choi, Y; Joo, Y; Jung, SY; Kim, HS; Kim, JH; Lee, YK; Shin, KY; Suh, YH | 1 |
| Gagnon, E; Robinson, B; Small, BJ | 1 |
| Ancelin, ML; Christen, Y; Ritchie, K | 1 |
| Araszkiewicz, A; Dziaman, T; Gackowski, D; Klimarczyk, M; Nicpon, K; Olinski, R; Rozalski, R; Siomek, A | 1 |
| Yaffe, K | 1 |
| Bonitsis, NG; Ioannidis, JP; Tatsioni, A | 1 |
| Busciglio, J; Deshpande, A; Moreira, PI; Oliveira, CR; Pereira, C; Proença, T; Resende, R | 1 |
| Clausen, J | 1 |
| Behl, C; Holsboer, F; Trapp, T; Widmann, M | 1 |
| Abe, T; Hamato, F; Nakanishi, M; Sasaki, K; Takahashi, S; Tohgi, H | 1 |
| Nakashima, K; Takahashi, K | 1 |
| Ahlskog, JE; Kokmen, E; Low, PA; Nickander, KK; Petersen, RC; Tyce, GM; Uitti, RJ | 1 |
| Ernesto, C; Growdon, J; Grundman, M; Klauber, MR; Sano, M; Schafer, K; Thal, LJ; Thomas, R; Woodbury, P | 1 |
| Cotman, CW; Ernesto, C; Growdon, J; Grundman, M; Klauber, MR; Pfeiffer, E; Sano, M; Schafer, K; Schneider, LS; Thal, LJ; Thomas, RG; Woodbury, P | 1 |
| Drachman, DA; Leber, P | 1 |
| Aejmelaeus, R; Alho, H; Hervonen, A; Ketelä, TM; Pirttilä, T | 1 |
| McIntosh, LJ; Troncoso, JC; Trush, MA | 1 |
| Pincus, MM | 1 |
| Kilander, L; Ohrvall, M | 1 |
| Adelman, A | 1 |
| Ala, TA; Bonilla, LE; Bordayo, EZ; Frey, WH; Garner, HP; Jensen, T; Mason, RP; Najarian, MM; Venters, HD | 1 |
| Arenas, J; Benito-León, J; de Bustos, F; Enríquez-de-Salamanca, R; Gasalla, T; Guillamón, F; Jiménez-Jiménez, FJ; Molina, JA; Ortí-Pareja, M; Rubio, JC; Tallón-Barranco, A | 1 |
| Butterfield, DA; Dhillon, H; Drake, J; Koppal, T; Prasad, MR; Subramaniam, R | 1 |
| Doung, A; Draczynska-Lusiak, B; Sun, AY | 1 |
| Hendrie, HC | 1 |
| Cummings, JL; Tom, T | 1 |
| Schneider, LS | 1 |
| Heinemann, U; Müller, W; Schuchmann, S | 1 |
| Vatassery, GT | 1 |
| Cummings, JL | 2 |
| Sunderland, T; Tune, LE | 1 |
| Beckett, LA; Bennett, DA; Evans, DA; Field, TS; Hebert, LE; Morris, MC; Scherr, PA | 1 |
| Butterfield, DA; Drake, J; Green, M; Jordan, B; Koppal, T; Subramaniam, R; Yatin, S | 1 |
| Sloane, PD | 1 |
| Birlouez-Aragon, I; Nourhashémi, F; Rivière, S; Vellas, B | 1 |
| Han, D; Kameyama, T; Nabeshima, T; Senzaki, K; Tanaka, T; Yamada, K | 1 |
| Davis, KL | 1 |
| Nicholson, CR | 1 |
| Aksenov, M; Butterfield, DA; Yatin, SM | 1 |
| Post, SG | 1 |
| Pryse-Phillips, W | 1 |
| Behl, C | 1 |
| Fernandes, AI; Fernandes, MA; Grazina, MM; Nogueira, AJ; Oliveira, CR; Oliveira, LM; Proenca, MT; Santana, I; Santiago, B | 1 |
| Bauer, T; Dysken, M; Vatassery, GT | 1 |
| Burke, JR; Morgenlander, JC | 1 |
| Floyd, RA | 1 |
| Doody, RS | 1 |
| Blackburn, G | 1 |
| Butterfield, DA; Koppal, T; Subramaniam, R; Yatin, S | 1 |
| Grundman, M | 1 |
| Moreira, P; Oliveira, CR; Pereira, C; Santos, MS; Seiça, R | 1 |
| Arlt, S; Beisiegel, U; Buhmann, C; Kontush, A; Mann, U; Müller-Thomsen, T; Schippling, S; Stürenburg, HJ | 1 |
| Cummings, J; Fillit, H | 1 |
| Arai, H; Hanawa, T; Sasaki, H; Suzuki, T; Toriizuka, K; Yamada, H | 1 |
| Aragno, M; Boccuzzi, G; Brignardello, E; Danni, O; Parola, M; Parola, S; Tamagno, E | 1 |
| Hashimoto, Y; Ito, Y; Niikura, T; Nishimoto, I | 1 |
| Breitner, JC | 1 |
| Gauthier, S | 1 |
| Birks, J; Tabet, N | 1 |
| Delanty, N; Praticò, D | 1 |
| Chen, GG; Doraiswamy, PM; McLendon, BM | 1 |
| Reichman, WE | 1 |
| Averill, D; Christen, Y; Davignon, J; Krzywkowski, P; Lussier-Cacan, S; Poirier, J; Ramassamy, C; Theroux, L | 1 |
| Service, RF | 1 |
| Eckert, A; Haass, C; Leutz, S; Marques, C; Müller, WE; Romig, H; Steiner, B | 1 |
| Joseph, JA; Youdim, KA | 1 |
| Dreon, DM; Peroutkal, SJ | 1 |
| Cummings, JL; Cyrus, PA; Masterman, D; Nadel, A | 1 |
| Bourdel-Marchasson, I; Decamps, A; Delmas-Beauvieux, MC; Emeriau, JP; Peuchant, E; Rainfray, M; Reignier, B; Richard-Harston, S | 1 |
| Arlt, S; Beisiegel, U; Kontush, A; Lührs, C; Mann, U; Müller-Thomsen, T; Ujeyl, A | 1 |
| Goldbeck, RA; Harris, T; Mill, T; Winterle, JS | 1 |
| Hampel, H; Möller, HJ; Padberg, F | 1 |
| Wettstein, A | 1 |
| Cho, HY; Heo, HJ; Heo, TR; Hong, B; Kim, CJ; Kim, EK; Kim, HK; Kim, SK; Shin, DH | 1 |
| Woo, K | 1 |
| Breteler, MM; Engelhart, MJ; Geerlings, MI; Hofman, A; Ruitenberg, A; van Swieten, JC; Witteman, JC | 1 |
| Aggarwal, N; Bennett, DA; Bienias, JL; Evans, DA; Morris, MC; Scherr, PA; Tangney, CC; Wilson, RS | 1 |
| Behl, C; Moosmann, B | 1 |
| Cayley, AC; Fielden, P; Frost, PG; Niriella, DC; Roche, S; Zaman, Z | 1 |
| Corrigan, FM; Horrobin, DF; Van Rhijn, A | 1 |
| Dormandy, T; Haines, A; Iliffe, S; Morgan, P; Wood, B | 1 |
| Adams, JD; Klaidman, LK; Miller, CA; Odunze, IN; Shen, HC | 1 |
| Bowen, DM; Metcalfe, T; Muller, DP | 2 |
| Cuny, G; Dubois, F; Jeandel, C; Nabet-Belleville, F; Nicolas, MB; Penin, F | 1 |
| Dickerson, JW; Holland, AJ; Jackson, CV; Williams, CA | 1 |
| Kobayashi, K | 1 |
| Hirai, S | 1 |
87 review(s) available for d-alpha tocopherol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
A meta-analysis of peripheral tocopherol levels in age-related cognitive decline and Alzheimer's disease.
Topics: alpha-Tocopherol; Alzheimer Disease; Cognition; Cognitive Dysfunction; Humans; Vitamin E | 2021 |
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Topics: Activities of Daily Living; alpha-Tocopherol; Alzheimer Disease; Antioxidants; Cognition; Cognitive Dysfunction; Disease Progression; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Vitamin E | 2017 |
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Topics: alpha-Tocopherol; Alzheimer Disease; Antioxidants; Cognitive Dysfunction; Disease Progression; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Vitamin E | 2017 |
Implications of apolipoprotein E genotype on inflammation and vitamin E status.
Topics: alpha-Tocopherol; Alzheimer Disease; Animals; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Cardiovascular Diseases; Genotype; Germany; Humans; Inflammation; Mice; Polymorphism, Genetic; RNA, Messenger; Vitamin E | 2010 |
The involvement of lipid radical cycles and the adenine nucleotide translocator in neurodegenerative diseases.
Topics: Adenine Nucleotide Translocator 1; Adenosine Triphosphate; alpha-Tocopherol; Alzheimer Disease; Animals; Brain; Cytochromes b5; Fatty Acids, Unsaturated; Free Radicals; Humans; Lipid Peroxidation; Mitochondria; Mitochondrial Membranes; Pyruvaldehyde | 2007 |
Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer disease.
Topics: Adenosine Diphosphate; Aging; Aldehydes; alpha-Tocopherol; Alzheimer Disease; Animals; Antioxidants; Apoptosis; Cell Membrane; Energy Metabolism; Fatty Acids, Unsaturated; Humans; Lipid Peroxidation; Mitochondria; Mitochondrial ADP, ATP Translocases; Molecular Structure; NAD; Oxidation-Reduction; Reactive Oxygen Species | 2007 |
Enjoy Carefully: The Multifaceted Role of Vitamin E in Neuro-Nutrition.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Antioxidants; Cholesterol; Dietary Supplements; Genetic Variation; Humans; Mice; Neurodegenerative Diseases; Nutritional Sciences; Nutritional Status; Rats; Vitamin E | 2021 |
Potential innovation against Alzheimer's disorder: a tricomponent combination of natural antioxidants (vitamin E, quercetin, and basil oil) and the development of its intranasal delivery.
Topics: Administration, Intranasal; Alzheimer Disease; Antioxidants; Brain; Humans; Ocimum; Plant Oils; Quercetin; Vitamin E | 2022 |
Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer's Disease, and Other Dementias.
Topics: Alzheimer Disease; Animals; Antioxidants; Cognition; Cognitive Dysfunction; Mice; Vitamin E; Vitamins | 2022 |
Nutrients and amyloid β status in the brain: A narrative review.
Topics: Aluminum; Alzheimer Disease; Amyloid beta-Peptides; Brain; Calcium; Cholesterol; Copper; Diet, Mediterranean; Fatty Acids; Fatty Acids, Unsaturated; Folic Acid; Fructose; Humans; Lipoproteins, LDL; Manganese; Sodium; Sucrose; Triglycerides; Vitamin B 12; Vitamin D; Vitamin E; Vitamins; Zinc | 2022 |
Effect of antioxidant intake patterns on risks of dementia and cognitive decline.
Topics: Alzheimer Disease; Antioxidants; Ascorbic Acid; Cognitive Dysfunction; Humans; Prospective Studies; Vitamin E; Vitamins | 2023 |
Vitamin E and Its Molecular Effects in Experimental Models of Neurodegenerative Diseases.
Topics: Alzheimer Disease; Cognition; Humans; Models, Theoretical; Neurodegenerative Diseases; Vitamin E | 2023 |
Vitamin E and Alzheimer's disease: what do we know so far?
Topics: Alzheimer Disease; Cholesterol; Diet; Dietary Supplements; Disease Progression; Humans; Male; Nutritional Status; Treatment Outcome; Vitamin E | 2019 |
Effects of vitamin E on neurodegenerative diseases: an update.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Humans; Neurodegenerative Diseases; Parkinson Disease; Stroke; Vitamin E | 2021 |
Do low-serum vitamin E levels increase the risk of Alzheimer disease in older people? Evidence from a meta-analysis of case-control studies.
Topics: Aged; Alzheimer Disease; Case-Control Studies; China; Humans; Prospective Studies; Risk Factors; Vitamin E | 2018 |
Role of Vitamin E in the Treatment of Alzheimer's Disease: Evidence from Animal Models.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Clinical Trials as Topic; Dietary Supplements; Disease Models, Animal; Drug Evaluation, Preclinical; Drug Therapy, Combination; Humans; Oxidative Stress; Protein Aggregation, Pathological; Reactive Oxygen Species; tau Proteins; Treatment Outcome; Vitamin E | 2017 |
Alzheimer's disease: Only prevention makes sense.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Antibodies, Monoclonal; Antioxidants; Clinical Trials as Topic; Disease Models, Animal; Healthy Lifestyle; Humans; Mice; Middle Aged; Nootropic Agents; Treatment Failure; Vitamin E | 2018 |
[Meta-analysis of vitamin C, vitamin E and β-carotene levels in the plasma of Alzheimer's disease patients].
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ascorbic Acid; beta Carotene; Female; Humans; Male; Reference Values; Vitamin E | 2018 |
Effect of dietary interventions in mild cognitive impairment: a systematic review.
Topics: Alzheimer Disease; Attention; Biomarkers; Cognition; Cognitive Dysfunction; Dementia; Diet; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Eicosapentaenoic Acid; Executive Function; Folic Acid; Ginkgo biloba; Humans; Language; Neuropsychological Tests; Phospholipids; Randomized Controlled Trials as Topic; Vitamin E | 2018 |
The Effectiveness of Vitamin E Treatment in Alzheimer's Disease.
Topics: Alzheimer Disease; Clinical Trials as Topic; Cognition Disorders; Humans; Oxidative Stress; Treatment Outcome; Vitamin E | 2019 |
Effects of vitamin E supplementation on the risk and progression of AD: a systematic review and meta-analysis.
Topics: Alzheimer Disease; Dietary Supplements; Disease Progression; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Vitamin E | 2021 |
Dietary antioxidants, cognitive function and dementia--a systematic review.
Topics: Alzheimer Disease; Antioxidants; Ascorbic Acid; Carotenoids; Cognition; Cross-Sectional Studies; Dementia; Dementia, Vascular; Diet; Female; Flavonoids; Humans; Longitudinal Studies; Male; MEDLINE; Risk Factors; Vitamin E | 2013 |
Dietary and lifestyle guidelines for the prevention of Alzheimer's disease.
Topics: Alzheimer Disease; Diet, Vegetarian; Exercise; Fatty Acids; Humans; Life Style; Nutrition Policy; Risk; Trans Fatty Acids; Vitamin B 12; Vitamin E | 2014 |
Effects of vitamin E on cognitive performance during ageing and in Alzheimer's disease.
Topics: Age Factors; Aged; Aging; Alzheimer Disease; Animals; Antioxidants; Brain; Cognition; Dietary Supplements; Humans; Middle Aged; Oxidative Stress; Treatment Outcome; Vitamin E | 2014 |
[Vitamin E and Alzheimer's Disease].
Topics: Alzheimer Disease; Antioxidants; Cognitive Dysfunction; Disease Progression; Humans; Oxidative Stress; Vitamin E | 2015 |
The Impact of Vitamin E and Other Fat-Soluble Vitamins on Alzheimer´s Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Humans; Lipid Metabolism; Vitamin A; Vitamin D; Vitamin E; Vitamin K | 2016 |
Vitamin E for Alzheimer's disease and mild cognitive impairment.
Topics: Alzheimer Disease; Antioxidants; Disease Progression; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Vitamin E | 2008 |
Pharmacological treatment in moderate-to-severe Alzheimer's disease.
Topics: Alzheimer Disease; Donepezil; Double-Blind Method; Humans; Indans; Memantine; Phenylcarbamates; Piperidines; Placebos; Randomized Controlled Trials as Topic; Rivastigmine; Selegiline; Severity of Illness Index; Vitamin E | 2008 |
Oxidative stress hypothesis in Alzheimer's disease: a reappraisal.
Topics: Alzheimer Disease; Animals; Antioxidants; Humans; Nerve Degeneration; Oxidative Stress; Vitamin E | 2008 |
Why vitamin E therapy fails for treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Humans; Reactive Oxygen Species; Treatment Failure; Vitamin E | 2010 |
Neuronutrition and Alzheimer's disease.
Topics: Aged; Alcohol Drinking; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Avitaminosis; Brain; Diet; Energy Intake; Female; Homocysteine; Humans; Hypercholesterolemia; Male; Middle Aged; Nerve Degeneration; Nutrition Therapy; Oxidative Stress; Phosphorylation; Point Mutation; Vitamin E | 2010 |
Vitamin E forms in Alzheimer's disease: a review of controversial and clinical experiences.
Topics: Alzheimer Disease; Antioxidants; Cognition Disorders; Humans; Vitamin E | 2010 |
Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease.
Topics: Alkaloids; Alzheimer Disease; Amino Acids; Animals; Cholinesterase Inhibitors; Dietary Supplements; Disease Progression; Docosahexaenoic Acids; Donepezil; Drug Approval; Galantamine; Ginkgo biloba; Half-Life; History, 20th Century; Humans; Indans; Memantine; Nootropic Agents; Phenylcarbamates; Phytotherapy; Piperidines; Psychotropic Drugs; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Rivastigmine; Sesquiterpenes; Vitamin B Complex; Vitamin E | 2012 |
Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis.
Topics: Alzheimer Disease; Antioxidants; Ascorbic Acid; beta Carotene; Dietary Supplements; Humans; Oxidative Stress; Risk Factors; Vitamin E | 2012 |
Vitamin E for Alzheimer's dementia and mild cognitive impairment.
Topics: Alzheimer Disease; Antioxidants; Cognitive Dysfunction; Disease Progression; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Vitamin E | 2012 |
Antioxidant strategies for Alzheimer's disease.
Topics: Alzheimer Disease; Antioxidants; Dietary Supplements; Disease Progression; Drug Therapy, Combination; Ginkgo biloba; Humans; Oxidation-Reduction; Oxidative Stress; Vitamin E | 2002 |
Vitamin E and neurodegenerative disorders associated with oxidative stress.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Biological Availability; Dyskinesias; Humans; Huntington Disease; Intestinal Absorption; Lipid Peroxidation; Multiple Sclerosis; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Vitamin E | 2002 |
The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Behavior Therapy; Caregivers; Cholinesterase Inhibitors; Combined Modality Therapy; Free Radical Scavengers; Humans; Middle Aged; Nootropic Agents; Vitamin E | 2002 |
[Antioxidants to slow aging, facts and perspectives].
Topics: Aging; Alzheimer Disease; Animals; Antioxidants; Arteriosclerosis; Ascorbic Acid; Carotenoids; Cataract; Chronic Disease; Disease Models, Animal; Evidence-Based Medicine; Free Radicals; Humans; Lutein; Macular Degeneration; Neoplasms; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Vitamin E | 2002 |
Which studies of therapy merit credence? Vitamin E and estrogen therapy as cautionary examples.
Topics: Aged; Alzheimer Disease; Antioxidants; Cardiovascular Diseases; Estrogen Replacement Therapy; Evidence-Based Medicine; Female; Humans; Middle Aged; Quality of Life; Risk; Vitamin E | 2002 |
[Mild Cognitive Impairment: potential therapeutics].
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Donepezil; Dopamine Agonists; Humans; Indans; Neuropsychological Tests; Piperidines; Severity of Illness Index; Vitamin E | 2002 |
Antioxidant vitamins E and C and risk of Alzheimer's disease.
Topics: Aged; Aging; Alzheimer Disease; Antioxidants; Ascorbic Acid; Female; Humans; Male; Middle Aged; Risk Factors; Vitamin E | 2003 |
Noncholinergic treatment options for Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Animals; Anticholesteremic Agents; Antioxidants; Behavioral Symptoms; Clinical Trials as Topic; Cognition Disorders; Estrogens; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Middle Aged; Patient Selection; Research Design; Selegiline; Vitamin E | 2003 |
Choosing treatment for Alzheimer's patients and their caregivers.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents; Anticonvulsants; Antipsychotic Agents; Caregivers; Cholinesterase Inhibitors; Depression; Ginkgo biloba; Homocysteine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Phytotherapy; Plant Extracts; Professional-Family Relations; Psychotic Disorders; Receptors, N-Methyl-D-Aspartate; Risk Factors; Social Support; Vitamin E | 2003 |
Dementia.
Topics: Alzheimer Disease; Anticonvulsants; Antipsychotic Agents; Carbamates; Donepezil; Galantamine; Ginkgo biloba; Humans; Indans; Nootropic Agents; Phenylcarbamates; Phosphatidylcholines; Physostigmine; Phytotherapy; Piperidines; Rivastigmine; Tacrine; Vitamin E | 2003 |
Pharmacologic treatment of Alzheimer's disease: an update.
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Drug Monitoring; Estrogens; Ginkgo biloba; Humans; Neuroprotective Agents; Phytotherapy; Practice Guidelines as Topic; Selegiline; Vitamin E | 2003 |
[Mild cognitive impairment].
Topics: Aging; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Diagnosis, Differential; Disease Progression; Humans; Psychiatric Status Rating Scales; Selegiline; Severity of Illness Index; Vitamin E | 2003 |
[Prognosis in Alzheimer's disease].
Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Humans; Indans; Mental Processes; Piperidines; Prognosis; Risk; Selegiline; Survival Rate; Time Factors; Vitamin E | 2004 |
[Vitamin E].
Topics: Alzheimer Disease; Animals; Antioxidants; Ascorbic Acid; Free Radical Scavengers; Free Radicals; Humans; Vitamin E; Vitamin E Deficiency | 2004 |
Oxidative stress in mild cognitive impairment and Alzheimer disease: a continuum.
Topics: Aged; Alzheimer Disease; Ascorbic Acid; Cognition Disorders; Erythrocytes; Humans; Oxidative Stress; Vitamin A; Vitamin E | 2004 |
Dementia.
Topics: Alzheimer Disease; Antipsychotic Agents; Benzodiazepines; Cognition; Dementia; Donepezil; Galantamine; Ginkgo biloba; Haloperidol; Humans; Indans; Memantine; Olanzapine; Phenylcarbamates; Physostigmine; Phytotherapy; Piperidines; Risperidone; Rivastigmine; Selegiline; Tacrine; Vitamin E | 2004 |
The protective role of vitamin E in vascular amyloid beta-mediated damage.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Antioxidants; Cerebrovascular Disorders; Humans; Oxidative Stress; Vitamin E | 2005 |
Vitamin E in neurodegenerative disorders: Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Ascorbic Acid; Brain; Humans; Lipid Peroxidation; Lipoproteins; Mice; Mice, Transgenic; Oxidative Stress; Vitamin E | 2004 |
Relationship between dementia and nutrition-related factors and disorders: an overview.
Topics: Alzheimer Disease; Antioxidants; Ascorbic Acid; Dementia; Diabetes Mellitus; Diet; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Nutrition Disorders; Nutritional Physiological Phenomena; Oxidative Stress; Risk Factors; Vitamin A; Vitamin B Complex; Vitamin E | 2005 |
Alpha-tocopherol: roles in prevention and therapy of human disease.
Topics: Alzheimer Disease; Antioxidants; Biological Transport; Cardiovascular Diseases; Humans; Neoplasms; Oxidative Stress; Vitamin E | 2005 |
Vitamin C and vitamin E for Alzheimer's disease.
Topics: Alzheimer Disease; Antioxidants; Ascorbic Acid; Humans; Randomized Controlled Trials as Topic; Vitamin E | 2005 |
Vitamin E supplementation in Alzheimer's disease, Parkinson's disease, tardive dyskinesia, and cataract: Part 2.
Topics: Alzheimer Disease; Antioxidants; Cataract; Clinical Trials as Topic; Dyskinesia, Drug-Induced; Humans; Parkinson Disease; Randomized Controlled Trials as Topic; Vitamin E | 2005 |
Clinical trials in mild cognitive impairment: lessons for the future.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Donepezil; Galantamine; Humans; Indans; Lactones; Neuropsychological Tests; Phenylcarbamates; Piperidines; Rivastigmine; Severity of Illness Index; Sulfones; Vitamin E | 2006 |
[Could intake of vitamins C and E inhibit development of Alzheimer dementia?].
Topics: Aged; Alzheimer Disease; Antioxidants; Ascorbic Acid; Humans; Middle Aged; Oxidative Stress; Risk Factors; Vitamin E | 2006 |
Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Humans; Memantine; Neuroprotective Agents; Nursing Homes; Patient Transfer; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Receptors, N-Methyl-D-Aspartate; Selegiline; Severity of Illness Index; Treatment Outcome; Vitamin E | 2006 |
Involvement of oxidative stress in Alzheimer disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Cell Death; Disease Models, Animal; Disease Progression; Genetic Predisposition to Disease; Humans; Neurons; Neuroprotective Agents; Oxidative Stress; Plaque, Amyloid; Risk Factors; Risk Reduction Behavior; Vitamin E | 2006 |
Early identification of cognitive deficits: preclinical Alzheimer's disease and mild cognitive impairment.
Topics: Adult; Alzheimer Disease; Cognition Disorders; Disease Progression; Donepezil; Humans; Indans; Neuropsychological Tests; Nootropic Agents; Piperidines; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Time Factors; Vitamin E | 2007 |
Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Cognition Disorders; Flavonoids; Humans; Reactive Oxygen Species; Superoxide Dismutase; Vitamin E; Wine | 2007 |
[Fat-soluble vitamin therapy in senile dementia and Parkinson's disease].
Topics: Aged; Alzheimer Disease; Free Radicals; Humans; Parkinson Disease; Vitamin E | 1993 |
Epidemiology of dementia and Alzheimer's disease.
Topics: Age Distribution; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Estradiol; Female; Humans; Male; Prevalence; Risk Factors; Vitamin E | 1998 |
Alzheimer's disease: the search for causes and treatments--Part II.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Anti-Inflammatory Agents, Non-Steroidal; Apolipoproteins E; Cholinesterase Inhibitors; Estrogens; Humans; Plant Extracts; Vitamin E | 1998 |
Vitamin E and other endogenous antioxidants in the central nervous system.
Topics: Alzheimer Disease; Antioxidants; Central Nervous System; Dyskinesia, Drug-Induced; Humans; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Vitamin E | 1998 |
New cholinergic therapies: treatment tools for the psychiatrist.
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cholinergic Agents; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Estrogen Replacement Therapy; Estrogens; Female; Humans; Indans; Male; Piperidines; Selective Serotonin Reuptake Inhibitors; Selegiline; Tacrine; Vitamin E | 1998 |
New drugs for Alzheimer's disease.
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition; Drugs, Investigational; Ergoloid Mesylates; Estrogens; Humans; Neuroprotective Agents; Vitamin E | 1998 |
Advances in the treatment of Alzheimer's disease.
Topics: Algorithms; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Decision Trees; Diagnosis, Differential; Disease Progression; Estrogens; Humans; Mental Disorders; Terminal Care; Vitamin E | 1998 |
Future scenarios for the prevention and delay of Alzheimer disease onset in high-risk groups. An ethical perspective.
Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Estrogen Replacement Therapy; Ethics, Medical; Genetic Predisposition to Disease; Genetic Testing; Ginkgo biloba; Health Priorities; Humans; Phytotherapy; Plants, Medicinal; Risk Factors; Vitamin E | 1999 |
Do we have drugs for dementia? No.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Dementia; Donepezil; Ginkgo biloba; Humans; Indans; Neuroprotective Agents; Nootropic Agents; Phytotherapy; Piperidines; Plants, Medicinal; Selegiline; Tacrine; Vitamin E | 1999 |
High doses of vitamin E in the treatment of disorders of the central nervous system in the aged.
Topics: Aged; Alzheimer Disease; Antioxidants; Central Nervous System Diseases; Dose-Response Relationship, Drug; Geriatrics; Humans; Oxidative Stress; Parkinson Disease; Vitamin E | 1999 |
Update on Alzheimer's disease. Promising advances in detection and treatment.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Donepezil; Estrogen Replacement Therapy; Estrogens; Female; Humans; Indans; Piperidines; Vitamin E | 1999 |
Antioxidants, oxidative stress, and degenerative neurological disorders.
Topics: Alzheimer Disease; Animals; Antioxidants; Brain; Cyclic N-Oxides; Free Radicals; Humans; Mitogen-Activated Protein Kinases; Neurodegenerative Diseases; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Signal Transduction; Vitamin E | 1999 |
Therapeutic standards in Alzheimer disease.
Topics: Activities of Daily Living; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Donepezil; Humans; Indans; Piperidines; Quality of Health Care; Quality of Life; Treatment Outcome; Vitamin E | 1999 |
Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cell Culture Techniques; Cell Membrane; Cells, Cultured; Hippocampus; Humans; Neocortex; Neurons; Oxidative Stress; Synaptosomes; Vitamin E | 1999 |
Vitamin E and Alzheimer disease: the basis for additional clinical trials.
Topics: Alzheimer Disease; Animals; Antioxidants; Brain; Clinical Trials as Topic; Cognition Disorders; Humans; Lipid Peroxidation; Monoamine Oxidase Inhibitors; Oxidative Stress; Selegiline; Vitamin E | 2000 |
[A new interventional strategy for Alzheimer's disease by Japanese herbal medicine].
Topics: Aged; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Avoidance Learning; Brain; Choline O-Acetyltransferase; Clinical Trials as Topic; Cognition; Drugs, Chinese Herbal; Estrogens; Female; Humans; Nerve Growth Factor; Rats; Stimulation, Chemical; Vitamin E | 2000 |
Vitamin E for Alzheimer's disease.
Topics: Alzheimer Disease; Humans; Outcome Assessment, Health Care; Randomized Controlled Trials as Topic; Vitamin E | 2000 |
Oxidative injury in diseases of the central nervous system: focus on Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Antioxidants; Ascorbic Acid; Benzoquinones; Central Nervous System; Central Nervous System Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Free Radicals; Ginkgo biloba; Humans; Lipid Peroxidation; Neuroprotective Agents; Oxidation-Reduction; Phytotherapy; Plants, Medicinal; Selegiline; Ubiquinone; Vitamin E | 2000 |
Alzheimer's disease: clinical treatment options.
Topics: Aged; Alzheimer Disease; Anticonvulsants; Antidepressive Agents; Antioxidants; Antipsychotic Agents; Cholinesterase Inhibitors; Clinical Trials as Topic; Disease Progression; Estrogens; Humans; Nootropic Agents; United States; Vitamin E | 2000 |
A possible emerging role of phytochemicals in improving age-related neurological dysfunctions: a multiplicity of effects.
Topics: Alzheimer Disease; Animals; Ascorbic Acid; Capsicum; Carotenoids; Flavonoids; Fruit; Garlic; Ginkgo biloba; Humans; Nervous System Diseases; Panax; Parkinson Disease; Phenols; Phytotherapy; Plants, Medicinal; Polymers; Polyphenols; Tea; Vitamin E | 2001 |
Treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Antioxidants; Caregivers; Cholinesterase Inhibitors; Drug Interactions; Humans; Psychotropic Drugs; Vitamin E | 2001 |
New tools for taking control of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Humans; Practice Guidelines as Topic; Risk Factors; Vitamin E | 2001 |
Alzheimer's disease: recent progress and prospects--Part III.
Topics: Alzheimer Disease; Antioxidants; Apolipoprotein E4; Apolipoproteins E; Genetic Therapy; Ginkgo biloba; Humans; Nerve Growth Factors; Oxidative Stress; Phytotherapy; Plant Preparations; Research; Vitamin E | 2001 |
Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Estrogens; Free Radical Scavengers; Humans; Neurons; Neuroprotective Agents; Oxidative Stress; Signal Transduction; Vitamin E | 2002 |
29 trial(s) available for d-alpha tocopherol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Caregivers; Cognition Disorders; Cohort Studies; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Humans; Male; Middle Aged; Mood Disorders; Time Factors; Vitamin B 12 | 2015 |
Maintenance of Cognitive Performance and Mood for Individuals with Alzheimer's Disease Following Consumption of a Nutraceutical Formulation: A One-Year, Open-Label Study.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Cognition Disorders; Dietary Supplements; Disease Progression; Female; Folic Acid; Follow-Up Studies; Humans; Male; Mood Disorders; Neuropsychological Tests; Psychiatric Status Rating Scales; Time Factors; Vitamin B 12 | 2016 |
Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation.
Topics: alpha-Tocopherol; Alzheimer Disease; Antioxidants; Ascorbic Acid; Down Syndrome; Drug Combinations; Feasibility Studies; Female; Humans; Male; Middle Aged; Pilot Projects; Thioctic Acid; Treatment Outcome | 2011 |
Impairment of the ABCA1 and SR-BI-mediated cholesterol efflux pathways and HDL anti-inflammatory activity in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Apolipoprotein A-I; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; Cell Line; Cholesterol, HDL; Female; Gene Expression Regulation; Humans; Inflammation; Intercellular Adhesion Molecule-1; Male; Malondialdehyde; Oxidative Stress; Scavenger Receptors, Class B | 2012 |
Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Ascorbic Acid; Biomarkers; Cholinesterase Inhibitors; Dietary Supplements; Double-Blind Method; F2-Isoprostanes; Female; Follow-Up Studies; Humans; Male; Memantine; Mental Status Schedule; Middle Aged; Peptide Fragments; Retrospective Studies; tau Proteins; Thioctic Acid; Ubiquinone | 2012 |
Supplementation With Carotenoids, Omega-3 Fatty Acids, and Vitamin E Has a Positive Effect on the Symptoms and Progression of Alzheimer's Disease.
Topics: Alzheimer Disease; Carotenoids; Dietary Supplements; Double-Blind Method; Fatty Acids, Omega-3; Humans; Quality of Life; Vitamin E | 2022 |
Association of Antioxidant Supplement Use and Dementia in the Prevention of Alzheimer's Disease by Vitamin E and Selenium Trial (PREADViSE).
Topics: Aged; Alzheimer Disease; Antioxidants; Dementia; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Selenium; Vitamin E | 2017 |
Vitamin E and memantine in Alzheimer's disease: clinical trial methods and baseline data.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Humans; Longitudinal Studies; Male; Memantine; Psychiatric Status Rating Scales; Veterans; Vitamin E | 2014 |
Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Caregivers; Cholinesterase Inhibitors; Disease Progression; Dopamine Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Memantine; Middle Aged; Severity of Illness Index; Treatment Outcome; Vitamin E | 2014 |
Longitudinal plasma amyloid beta in Alzheimer's disease clinical trials.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Biomarkers; Blood Chemical Analysis; Cognitive Dysfunction; Disease Progression; Donepezil; Female; Heterozygote; Humans; Indans; Longitudinal Studies; Male; Nootropic Agents; Peptide Fragments; Piperidines; Severity of Illness Index; Simvastatin; Vitamin E | 2015 |
Tolerability and safety of Souvenaid in patients with mild Alzheimer's disease: results of multi-center, 24-week, open-label extension study.
Topics: Aged; Alzheimer Disease; Beverages; Docosahexaenoic Acids; Double-Blind Method; Erythrocytes; Fatty Acids; Female; Food, Formulated; Humans; Male; Memory; Neuropsychological Tests; Nootropic Agents; Patient Compliance; Treatment Outcome; Vitamin E | 2015 |
Self-Reported Sleep Apnea and Dementia Risk: Findings from the Prevention of Alzheimer's Disease with Vitamin E and Selenium Trial.
Topics: Aged; Alleles; Alzheimer Disease; Apolipoprotein E4; Biomarkers; Canada; Dementia; Genotype; Humans; Male; Middle Aged; Neuropsychological Tests; Puerto Rico; Risk; Selenium; Self Report; Sleep Apnea Syndromes; United States; Vitamin E | 2016 |
Periventricular white matter hyperintensities increase the likelihood of progression from amnestic mild cognitive impairment to dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Antioxidants; Atrophy; Brain; Cerebral Ventricles; Cholinesterase Inhibitors; Cognition Disorders; Dementia; Disease Progression; Donepezil; Double-Blind Method; Female; Humans; Image Processing, Computer-Assisted; Indans; Magnetic Resonance Imaging; Male; Piperidines; Prospective Studies; Temporal Lobe; Time Factors; Treatment Outcome; Vitamin E | 2008 |
3D comparison of low, intermediate, and advanced hippocampal atrophy in MCI.
Topics: Aged; Alzheimer Disease; Atrophy; Cognition Disorders; Disease Progression; Female; Follow-Up Studies; Functional Laterality; Hippocampus; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Magnetic Resonance Imaging; Male; Nootropic Agents; Severity of Illness Index; Vitamin E | 2010 |
Effect of vitamin E administration on the elevated oxygen stress and the telomeric and subtelomeric status in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Case-Control Studies; Dinoprost; Female; Humans; Male; Methylation; Oxidative Stress; Telomere; Telomere Homeostasis; Telomere Shortening; Time Factors; Vitamin E | 2012 |
Practice effects in a longitudinal, multi-center Alzheimer's disease prevention clinical trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Bias; Canada; Chi-Square Distribution; Cognition; Drug Therapy, Combination; Humans; Incidence; Linear Models; Longitudinal Studies; Male; Memory; Middle Aged; Neuropsychological Tests; Observer Variation; Predictive Value of Tests; Puerto Rico; Reproducibility of Results; Selenium; Time Factors; Treatment Outcome; United States; Vitamin E | 2012 |
A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial.
Topics: Aged; Alzheimer Disease; Antioxidants; Dietary Supplements; Double-Blind Method; Follow-Up Studies; Humans; Male; Middle Aged; Selenium; Vitamin E | 2013 |
Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Apolipoproteins E; Ascorbic Acid; Carotenoids; Cognition Disorders; Erythrocytes; Female; Glutathione Peroxidase; Humans; Male; Matched-Pair Analysis; Oxidative Stress; Plasma; Reference Values; Superoxide Dismutase; Uric Acid; Vitamin A; Vitamin E | 2003 |
Vitamin E and donepezil for the treatment of mild cognitive impairment.
Topics: Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Donepezil; Double-Blind Method; Humans; Indans; Nootropic Agents; Piperidines; Proportional Hazards Models; Treatment Failure; Vitamin E | 2005 |
Dementia and Alzheimer's disease in community-dwelling elders taking vitamin C and/or vitamin E.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Ascorbic Acid; Cohort Studies; Data Interpretation, Statistical; Dementia; Female; Humans; Longitudinal Studies; Male; Neuropsychological Tests; North Carolina; Oxidative Stress; Prospective Studies; Vitamin E | 2005 |
Determinants of platelet activation in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Aspirin; Body Mass Index; C-Reactive Protein; Case-Control Studies; Chromatography, High Pressure Liquid; Cross-Sectional Studies; Cyclooxygenase 2 Inhibitors; Dinoprost; Enzyme-Linked Immunosorbent Assay; Female; Humans; Interleukin-6; Lactones; Logistic Models; Male; Odds Ratio; Platelet Activation; Radioimmunoassay; Sulfones; Thromboxane B2; Tumor Necrosis Factor-alpha; Vitamin E | 2007 |
Donepezil and vitamin E for mild cognitive impairment.
Topics: Alzheimer Disease; Cognition Disorders; Donepezil; Humans; Indans; Long-Term Care; Piperidines; Treatment Outcome; Vitamin E | 2006 |
Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
Topics: Age Distribution; Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Antioxidants; Apolipoprotein E4; Cholinesterase Inhibitors; Cognition Disorders; Cohort Studies; Disease Progression; Donepezil; Female; Genotype; Humans; Indans; Linear Models; Male; Neuropsychological Tests; Piperidines; Placebo Effect; Predictive Value of Tests; Prognosis; Sex Distribution; Vitamin E | 2007 |
Concentrations of alpha-tocopherol and its quinone derivative in cerebrospinal fluid from patients with vascular dementia of the Binswanger type and Alzheimer type dementia.
Topics: Aged; Aging; Alzheimer Disease; Arteriosclerosis; Dementia, Vascular; Humans; Lipid Peroxides; Psychiatric Status Rating Scales; Vitamin E | 1994 |
Rationale and design of a multicenter study of selegiline and alpha-tocopherol in the treatment of Alzheimer disease using novel clinical outcomes. Alzheimer's Disease Cooperative Study.
Topics: Aged; Alzheimer Disease; Female; Humans; Male; Multicenter Studies as Topic; Neuropsychological Tests; Research Design; Selegiline; Vitamin E | 1996 |
A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Cognition; Disease Progression; Double-Blind Method; Drug Combinations; Female; Humans; Institutionalization; Male; Mental Status Schedule; Monoamine Oxidase Inhibitors; Proportional Hazards Models; Selegiline; Treatment Outcome; Vitamin E | 1997 |
Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents; Anxiety; Apolipoproteins E; Behavior; Cholinesterase Inhibitors; Cognition Disorders; Depression; Double-Blind Method; Estrogens; Female; Humans; Male; Neurologic Examination; Psychiatric Status Rating Scales; Retrospective Studies; Sex Factors; Trichlorfon; Vitamin E | 2001 |
Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease.
Topics: Age of Onset; Aged; Alzheimer Disease; Antioxidants; Apolipoprotein A-I; Apolipoproteins B; Apolipoproteins E; Ascorbic Acid; Cholesterol; Dietary Supplements; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Humans; Lipoproteins; Male; Middle Aged; Time Factors; Triglycerides; Vitamin E | 2001 |
Essential fatty acids in Alzheimer's disease.
Topics: Alzheimer Disease; Double-Blind Method; Drug Combinations; Fatty Acids, Essential; Humans; Oxidation-Reduction; Placebos; Selenium; Vitamin E; Zinc | 1991 |
167 other study(ies) available for d-alpha tocopherol and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Synthesis of donepezil-based multifunctional agents for the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Amides; Amyloid beta-Peptides; Catalytic Domain; Cholinesterase Inhibitors; Donepezil; Drug Design; Indans; Inhibitory Concentration 50; Models, Molecular; Piperidines; Structure-Activity Relationship | 2015 |
New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Topics: Acetylcholinesterase; Alzheimer Disease; Antineoplastic Agents; Butyrylcholinesterase; Catalytic Domain; Cell Line, Tumor; Cell Survival; Chemistry Techniques, Synthetic; Cholinesterase Inhibitors; Drug Design; Humans; Hydrazones; Molecular Docking Simulation; Piperidines | 2016 |
Development of naringenin-O-carbamate derivatives as multi-target-directed liagnds for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Butyrylcholinesterase; Carbamates; Cell Line; Cell Survival; Cholinesterase Inhibitors; Copper; Dose-Response Relationship, Drug; Drug Development; Flavanones; Humans; Molecular Structure; Neuroprotective Agents; Peptide Fragments; Protein Aggregates; Rats; Structure-Activity Relationship | 2022 |
Suppression of Amyloid-β Adsorption on Endoplasmic Reticulum Stress-Mimicking Membranes by α-Tocopherol and α-Tocotrienol.
Topics: Adsorption; alpha-Tocopherol; Alzheimer Disease; Amyloid beta-Peptides; Endoplasmic Reticulum Stress; Humans; Tocotrienols; Vitamin E | 2022 |
miRNAs and Alzheimer's Disease: Exploring the Role of Inflammation and Vitamin E in an Old-Age Population.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inflammation; Interleukin-8; Male; MicroRNAs; Vitamin E | 2023 |
Serum xanthophyll carotenoids are associated with estimated glomerular filtration rate in an aged cohort.
Topics: Aged; Aging; alpha-Tocopherol; Alzheimer Disease; Antioxidants; Cognitive Dysfunction; Cross-Sectional Studies; Female; gamma-Tocopherol; Glomerular Filtration Rate; Humans; Kidney Diseases; Male; Vitamin A; Xanthophylls | 2019 |
Comparative Effects of Alpha- and Gamma-Tocopherol on Mitochondrial Functions in Alzheimer's Disease In Vitro Model.
Topics: alpha-Tocopherol; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Apoptosis; Caspase 3; Cell Line, Tumor; Cytochromes c; gamma-Tocopherol; Humans; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Tocopherols | 2020 |
Multi-faceted therapeutic strategy for treatment of Alzheimer's disease by concurrent administration of etodolac and α-tocopherol.
Topics: alpha-Tocopherol; Alzheimer Disease; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Blood-Brain Barrier; Brain; Drug Synergism; Drug Therapy, Combination; Etodolac; Female; Mice; Mice, Transgenic; Oxidative Stress | 2019 |
Brain tocopherols related to Alzheimer's disease neuropathology in humans.
Topics: Aged; Aged, 80 and over; Aging; alpha-Tocopherol; Alzheimer Disease; Brain; Cohort Studies; Female; gamma-Tocopherol; Humans; Male; Neurofibrillary Tangles; Plaque, Amyloid | 2015 |
Vitamin E: Curse or Benefit in Alzheimer's Disease? A Systematic Investigation of the Impact of α-, γ- and δ-Tocopherol on Aß Generation and Degradation in Neuroblastoma Cells.
Topics: alpha-Tocopherol; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Amyloidosis; Antioxidants; Cell Line, Tumor; gamma-Tocopherol; Humans; Insulysin; Lipid Peroxidation; Neuroblastoma; Proteolysis; Tocopherols | 2015 |
Dietary pattern and antioxidants in plasma and erythrocyte in patients with mild cognitive impairment from China.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; alpha-Tocopherol; Alzheimer Disease; Antioxidants; Biomarkers; Body Mass Index; Body Weight; Case-Control Studies; China; Cholesterol, HDL; Cholesterol, LDL; Cognition; Cognitive Dysfunction; Deoxyguanosine; Diet; Erythrocytes; Female; Flavonoids; Humans; Life Style; Male; Malondialdehyde; Middle Aged; Nutrition Assessment; Oxidative Stress; Red Meat; Seafood; Socioeconomic Factors; Surveys and Questionnaires; Vitamin A | 2016 |
Dietary vitamin E, brain redox status and expression of Alzheimer's disease-relevant genes in rats.
Topics: alpha-Tocopherol; Alzheimer Disease; Animals; Antioxidants; Biomarkers; Brain Chemistry; Diet; Dose-Response Relationship, Drug; F2-Isoprostanes; gamma-Tocopherol; Gene Expression; Glutathione; Male; Oxidation-Reduction; Oxidative Stress; Random Allocation; Rats; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Tocopherols; Vitamins | 2009 |
Evaluation of uncertainty of measurement from method validation data: an application to the simultaneous determination of retinol and alpha-tocopherol in human serum by HPLC.
Topics: Adult; Aged; Algorithms; alpha-Tocopherol; Alzheimer Disease; Calibration; Chromatography, High Pressure Liquid; Guidelines as Topic; Humans; Indicators and Reagents; Male; Occupational Exposure; Quality Control; Reference Standards; Reproducibility of Results; Spectrometry, Fluorescence; Spectrophotometry, Ultraviolet; Vitamin A; Vitamins | 2009 |
Depletion of vitamin E increases amyloid beta accumulation by decreasing its clearances from brain and blood in a mouse model of Alzheimer disease.
Topics: alpha-Tocopherol; Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Blood-Brain Barrier; Blotting, Northern; Blotting, Western; Brain; Carrier Proteins; Dietary Supplements; Disease Models, Animal; Female; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Tocopherols | 2009 |
Ascorbic acid, alpha-tocopherol, and beta-carotene reduce oxidative stress and proinflammatory cytokines in mononuclear cells of Alzheimer's disease patients.
Topics: Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Antioxidants; Ascorbic Acid; beta Carotene; Female; Humans; Interleukin-1beta; Interleukin-4; Interleukin-6; Leukocytes, Mononuclear; Male; Middle Aged; Oxidative Stress; Reactive Oxygen Species | 2012 |
Hypothalamic digoxin, hemispheric chemical dominance, and Alzheimer's disease.
Topics: Aged; Albumins; alpha-Tocopherol; Alzheimer Disease; Ceruloplasmin; Digoxin; Dolichols; Dominance, Cerebral; Erythrocyte Membrane; Female; Free Radicals; Functional Laterality; Glycosaminoglycans; Humans; Hydroxymethylglutaryl CoA Reductases; Hypothalamus; Iron; Lysosomes; Magnesium; Male; Matched-Pair Analysis; Middle Aged; Phosphoprotein Phosphatases; Quinolinic Acid; Serotonin; Sodium-Potassium-Exchanging ATPase; Tryptophan | 2003 |
Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity.
Topics: Adaptor Proteins, Signal Transducing; alpha-Tocopherol; Alzheimer Disease; Amyloid beta-Protein Precursor; Antibodies, Monoclonal; Blotting, Western; Carrier Proteins; Cytotoxins; Diabetes Complications; Electrophoresis; Glycation End Products, Advanced; Glyoxal; Humans; Intracellular Space; Membrane Proteins; Peptide Fragments; Pyruvaldehyde; Thiolester Hydrolases | 2003 |
Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease.
Topics: Aged; alpha-Tocopherol; Alzheimer Disease; Antioxidants; Ascorbic Acid; Biomarkers; Cerebral Ventricles; Disease Progression; F2-Isoprostanes; Female; Humans; Lipid Peroxidation; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Statistics as Topic; tau Proteins | 2004 |
Apolipoprotein E isoforms and apolipoprotein AI protect from amyloid precursor protein carboxy terminal fragment-associated cytotoxicity.
Topics: alpha-Tocopherol; Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Antioxidants; Apolipoprotein A-I; Apolipoprotein E2; Apolipoproteins E; Cell Death; Cell Line; Drug Synergism; Humans; Lipoproteins, HDL; Mice; Neuroprotective Agents; Protein Isoforms | 2004 |
Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change.
Topics: Aged; alpha-Tocopherol; Alzheimer Disease; Antioxidants; Cognition; Confidence Intervals; Diet; Dietary Supplements; Female; gamma-Tocopherol; Humans; Incidence; Logistic Models; Longitudinal Studies; Male; Nutrition Assessment; Risk; Surveys and Questionnaires; Tocopherols; Vitamin E | 2005 |
Would caregivers of Alzheimer disease patients involve their relative in a decision to use an AD-slowing medication?
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Caregivers; Conflict, Psychological; Cost of Illness; Decision Making; Family; Female; Humans; Male; Mental Status Schedule; Middle Aged; Professional-Family Relations; Selegiline; Spouses | 2005 |
Cigarette smokers differ in their handling of natural (RRR) and synthetic (all rac) alpha-tocopherol: a biokinetic study in apoE4 male subjects.
Topics: Adult; alpha-Tocopherol; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Ascorbic Acid; Chromans; Coronary Disease; F2-Isoprostanes; Genetic Predisposition to Disease; Humans; Hyperlipoproteinemia Type V; Male; Middle Aged; Smoking; Tocopherols | 2006 |
Apolipoprotein E genotype and alpha-tocopherol modulate amyloid precursor protein metabolism and cell cycle regulation.
Topics: alpha-Tocopherol; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Cell Cycle; Cell Cycle Proteins; Cerebral Cortex; Diet; Female; Gene Expression; Genotype; Hippocampus; Membrane Fluidity; Mice; Mice, Transgenic; RNA, Messenger; Synaptosomes | 2007 |
Resistance of human cerebrospinal fluid to in vitro oxidation is directly related to its amyloid-beta content.
Topics: Adult; Aged; Aged, 80 and over; alpha-Tocopherol; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Ascorbic Acid; Case-Control Studies; Humans; In Vitro Techniques; Kinetics; Lipids; Lipoproteins; Middle Aged; Oxidation-Reduction; Oxidative Stress | 2001 |
[Free radical in Alzheimer's disease].
Topics: Aged; alpha-Tocopherol; Alzheimer Disease; Brain; Free Radicals; Glutathione; Humans; Middle Aged; Oxidative Stress; Tyrosine | 2002 |
Association Between Serum Vitamins and the Risk of Alzheimer's Disease in Chinese Population.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Case-Control Studies; China; Female; Folic Acid; Humans; Logistic Models; Male; Mental Status and Dementia Tests; Middle Aged; Riboflavin; Risk; Vitamin B 12; Vitamin D; Vitamin E | 2022 |
Design, synthesis, and evaluation of chalcone-Vitamin E-donepezil hybrids as multi-target-directed ligands for the treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Chalcone; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Design; Electrophorus; Humans; Ligands; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; PC12 Cells; Protein Aggregates; Rats; Structure-Activity Relationship; Vitamin E | 2022 |
Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease.
Topics: Alzheimer Disease; Dendrimers; Humans; Neuroprotection; Polyamines; Polyethylene Glycols; Tocopherols; Vitamin E | 2022 |
Combinations of Vitamin A and Vitamin E Metabolites Confer Resilience against Amyloid-β Aggregation.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Caenorhabditis elegans; Protein Aggregates; Vitamin A; Vitamin E; Vitamin K; Vitamins | 2023 |
Effects of Astaxanthin from Shrimp Shell on Oxidative Stress and Behavior in Animal Model of Alzheimer's Disease.
Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animal Shells; Animals; Cognitive Dysfunction; Disease Models, Animal; Lipid Peroxidation; Male; Maze Learning; Memory Disorders; Oxidative Stress; Penaeidae; Rats; Rats, Wistar; Vitamin E; Xanthophylls | 2019 |
Administration of Vitamin D
Topics: Alzheimer Disease; Animals; Behavior, Animal; Cholecalciferol; Disease Models, Animal; Male; Neurons; Oxidative Stress; Rats, Wistar; Vitamin E | 2020 |
Mental Component Score (MCS) from Health-Related Quality of Life Predicts Incidence of Dementia in U.S. Males.
Topics: Alzheimer Disease; Health Status; Humans; Incidence; Male; Outcome Assessment, Health Care; Quality of Life; Risk Factors; Surveys and Questionnaires; United States; Vitamin E | 2021 |
Natural antioxidants enhance the power of physical and mental activities versus risk factors inducing progression of Alzheimer's disease in rats.
Topics: Alzheimer Disease; Animals; Antioxidants; Ascorbic Acid; Catechin; Disease Models, Animal; Disease Progression; Male; Mental Health; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley; Risk Factors; Selenium; Vitamin E | 2021 |
Circulating vitamin E levels and Alzheimer's disease: a Mendelian randomization study.
Topics: Alzheimer Disease; Genetic Pleiotropy; Genome-Wide Association Study; Humans; Mendelian Randomization Analysis; Vitamin E; White People | 2018 |
Current approaches to the pharmacological treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Anti-Inflammatory Agents; Australia; Cholinesterase Inhibitors; Estrogens; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Memantine; Vitamin E | 2018 |
Vitamin E and Alzheimer's disease: the mediating role of cellular aging.
Topics: Alzheimer Disease; Biomarkers; Case-Control Studies; Cellular Senescence; Cohort Studies; Disease Progression; Female; Humans; Male; Oxidative Stress; Telomere Homeostasis; Vitamin E | 2020 |
Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Topics: Age Factors; Aged; Aging; Alzheimer Disease; Biomarkers; Chi-Square Distribution; Cholesterol; Cognition; Cognitive Dysfunction; Disease Progression; Female; Finland; Humans; Incidence; Linear Models; Logistic Models; Male; Odds Ratio; Oxidative Stress; Prospective Studies; Risk Factors; Time Factors; Tocopherols; Tocotrienols; Vitamin E | 2013 |
Vitamin E, memantine, and Alzheimer disease.
Topics: Alzheimer Disease; Antioxidants; Dopamine Agents; Female; Humans; Male; Memantine; Vitamin E | 2014 |
The value of vitamin E as a treatment for Alzheimer's disease remains unproven despite functional improvement, due to a lack of established effect on cognition or other outcomes from RCTs.
Topics: Alzheimer Disease; Antioxidants; Dopamine Agents; Female; Humans; Male; Memantine; Vitamin E | 2014 |
S-linolenoyl glutathione intake extends life-span and stress resistance via Sir-2.1 upregulation in Caenorhabditis elegans.
Topics: Aging; Alzheimer Disease; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Dietary Supplements; Forkhead Transcription Factors; Glutathione; Hydrogen Peroxide; Linolenic Acids; Longevity; Oxidative Stress; RNA Interference; RNA, Small Interfering; Sirtuins; Stress, Physiological; Transcription Factors; Transcriptional Activation; Vitamin E | 2014 |
High dose vitamin E may slow Alzheimer's decline.
Topics: Alzheimer Disease; Antioxidants; Clinical Trials as Topic; Dietary Supplements; Dose-Response Relationship, Drug; Humans; Risk Reduction Behavior; Vitamin E | 2014 |
[Vitamin E delays Alzheimer disease progression only slightly].
Topics: Aged; Alzheimer Disease; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Humans; Memantine; Randomized Controlled Trials as Topic; Vitamin E | 2014 |
Aβ and tau toxicities in Alzheimer's are linked via oxidative stress-induced p38 activation: protective role of vitamin E.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cells, Cultured; Disease Models, Animal; Hippocampus; Male; Mice; Mice, Transgenic; Neurons; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protective Agents; Rats; tau Proteins; Vitamin E | 2014 |
Caregivers' male gender is associated with poor nutrient intake in AD families (NuAD-trial).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ascorbic Acid; Body Mass Index; Calcium, Dietary; Caregivers; Dietary Fiber; Dietary Proteins; Energy Intake; Female; Finland; Humans; Male; Malnutrition; Nutrition Assessment; Nutritional Status; Sex Factors; Spouses; Vitamin E | 2014 |
Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
Topics: Aconitate Hydratase; Aged; Alzheimer Disease; Biomarkers; Blotting, Western; Cognitive Dysfunction; Disease Progression; Female; Free Radicals; Humans; Lymphocytes; Male; Mental Status Schedule; Mitochondria; Polymerase Chain Reaction; RNA, Messenger; Vitamin E | 2015 |
Association of increased carotid intima-media thickness and lower plasma levels of vitamin C and vitamin E in old age subjects: implications for Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Ascorbic Acid; Carotid Intima-Media Thickness; Female; Glutathione Peroxidase; Humans; Linear Models; Male; Superoxide Dismutase; Uric Acid; Vitamin A; Vitamin E | 2015 |
[What is new in 2014 for the specialist in hospital internal medicine? The point of view of university hospital chief residents].
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Arterial Pressure; Catheterization, Central Venous; Diverticulitis; Emergency Service, Hospital; Hospitals, University; Humans; Hypertension; Idiopathic Pulmonary Fibrosis; Internal Medicine; Kidney; Medical Staff, Hospital; Pneumonia; Pulmonary Embolism; Pyridones; Shock, Septic; Sympathectomy; Tumor Necrosis Factor-alpha; Ultrasonography; Venous Thromboembolism; Vitamin B 12 Deficiency; Vitamin E | 2015 |
Rice bran extract improves mitochondrial dysfunction in brains of aged NMRI mice.
Topics: Aging; Alzheimer Disease; Animals; Antioxidants; Brain; Citrate (si)-Synthase; Dietary Supplements; Disease Models, Animal; Female; Mice; Mitochondria; Nitroprusside; Oryza; Oxidative Stress; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylpropionates; Plant Extracts; Transcription Factors; Vitamin E | 2016 |
Alpha-tocopherol quinine ameliorates spatial memory deficits by reducing beta-amyloid oligomers, neuroinflammation and oxidative stress in transgenic mice with Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Behavior, Animal; Brain; Disease Models, Animal; Inflammation; Interleukins; Memory Disorders; Mice; Mice, Transgenic; Microglia; NF-kappa B; Oxidative Stress; Signal Transduction; Spatial Memory; Vitamin E | 2016 |
Use of Vitamin E and C Supplements for the Prevention of Cognitive Decline.
Topics: Aged; Aging; Alzheimer Disease; Antioxidants; Ascorbic Acid; Canada; Cognitive Dysfunction; Cohort Studies; Dementia; Dietary Supplements; Female; Humans; Male; Proportional Hazards Models; Risk Factors; Surveys and Questionnaires; Vitamin E | 2017 |
Tocotrienol Affects Oxidative Stress, Cholesterol Homeostasis and the Amyloidogenic Pathway in Neuroblastoma Cells: Consequences for Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Antioxidants; Cell Line; Cholesterol; Gene Expression Regulation, Enzymologic; Humans; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Tocotrienols; Vitamin E | 2016 |
Peripheral oxidative damage in mild cognitive impairment and mild Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Apolipoproteins E; Cognition Disorders; Erythrocytes; Female; Genotype; Glutathione Disulfide; Humans; Male; Neuropsychological Tests; Oxidative Stress; Severity of Illness Index; Vitamin E | 2008 |
Plasma urate and progression of mild cognitive impairment.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Boston; Cognition Disorders; Confounding Factors, Epidemiologic; Dementia; Disease Progression; Donepezil; Female; Humans; Incidence; Indans; Male; Middle Aged; Nootropic Agents; Piperidines; Prevalence; Survival Analysis; Uric Acid; Vitamin E | 2009 |
Changes in vitamin E prescribing for Alzheimer patients.
Topics: Aged; Alzheimer Disease; Cognition Disorders; Data Collection; Geriatric Psychiatry; Guideline Adherence; Heart Failure; Hospitalization; Humans; Incidence; Survival Rate; United States; Vitamin E | 2009 |
Effects of Pycnogenol and vitamin E on cognitive deficits and oxidative damage induced by intracerebroventricular streptozotocin in rats.
Topics: Alzheimer Disease; Animals; Antioxidants; Avoidance Learning; Cerebral Cortex; Choline O-Acetyltransferase; Cognition Disorders; Disease Models, Animal; Drug Evaluation, Preclinical; Flavonoids; Glutathione; Hippocampus; Infusions, Intraventricular; Male; Maze Learning; Oxidative Stress; Plant Extracts; Protein Carbonylation; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Streptozocin; Thiobarbituric Acid Reactive Substances; Vitamin E | 2009 |
Combination therapy of acetylcholinesterase inhibitor and vitamin E in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Retrospective Studies; Vitamin E | 2009 |
Antioxidants and cognitive training interact to affect oxidative stress and memory in APP/PSEN1 mice.
Topics: Aging; Alzheimer Disease; Amyloid beta-Protein Precursor; Analysis of Variance; Animals; Antioxidants; Ascorbic Acid; Behavior, Animal; Brain Chemistry; Cognition; Diet; Disease Models, Animal; Female; Liver; Male; Memory; Mice; Mice, Transgenic; Oxidative Stress; Plaque, Amyloid; Presenilin-1; Vitamin E | 2009 |
Vitamin E use is associated with improved survival in an Alzheimer's disease cohort.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Cohort Studies; Databases, Factual; Female; Humans; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Neuropsychological Tests; Risk Assessment; Survival Analysis; Vitamin E | 2009 |
High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age.
Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Cholesterol; Data Collection; Dementia; Female; Humans; Male; Neuropsychological Tests; Nutritional Status; Population; Proportional Hazards Models; Risk Reduction Behavior; Socioeconomic Factors; Sweden; Vitamin E | 2010 |
Report of the task force on designing clinical trials in early (predementia) AD.
Topics: Advisory Committees; Alzheimer Disease; Amyloidogenic Proteins; Biomarkers; Clinical Trials as Topic; Cognition; Consensus; Disease Progression; Donepezil; Drug Industry; Early Diagnosis; Europe; Humans; Indans; International Cooperation; Nootropic Agents; Outcome Assessment, Health Care; Patient Selection; Piperidines; Positron-Emission Tomography; Research Design; Treatment Outcome; United States; United States Food and Drug Administration; Vitamin E | 2011 |
[Effects of vitamin E on expression of PS-1 and production of Abeta in the hippocampus of female senile rats].
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Animals; Female; Hippocampus; Presenilin-1; Rats; Rats, Wistar; Vitamin E | 2007 |
Modulatory effects of vitamin E, acetyl-L-carnitine and α-lipoic acid on new potential biomarkers for Alzheimer's disease in rat model.
Topics: Alzheimer Disease; Animals; Antioxidants; Biomarkers; Brain; Carnitine; Cholinesterase Inhibitors; Dietary Supplements; Disease Models, Animal; Donepezil; Enzyme-Linked Immunosorbent Assay; Homocysteine; Indans; Insulin-Like Growth Factor I; Interleukin-1beta; Male; Piperidines; Rats; Rats, Sprague-Dawley; Thioctic Acid; Tumor Necrosis Factor-alpha; Vitamin E | 2012 |
Vitamin E and enzymatic/oxidative stress-driven oxysterols in amnestic mild cognitive impairment subtypes and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Biomarkers; Cognition Disorders; Female; Humans; Hydroxycholesterols; Male; Middle Aged; Oxidative Stress; Vitamin E | 2010 |
Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities.
Topics: Alzheimer Disease; Animals; Antioxidants; Brain; Calcium; Diabetes Complications; Diabetes Mellitus, Type 2; Electron Transport; Energy Metabolism; Gene Expression Regulation; Glutathione; Male; Mice; Mice, Transgenic; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxidative Stress; Phosphorylation; Random Allocation; Sucrose; Vitamin E | 2012 |
Effect of one-year vitamin C- and E-supplementation on cerebrospinal fluid oxidation parameters and clinical course in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Ascorbic Acid; Female; Humans; Kinetics; Lipid Peroxidation; Male; Middle Aged; Oxidation-Reduction; Vitamin E | 2012 |
Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Aβ42.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Blotting, Western; Cell Survival; Cells, Cultured; Chromans; Congo Red; Female; Free Radical Scavengers; Mutation; Neurons; Neurotoxins; Oxidative Stress; Peptide Fragments; Pregnancy; Protein Conformation; Rats; Rats, Wistar; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles; Vitamin E | 2012 |
Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.
Topics: Aged; Alzheimer Disease; Biomarkers; Chromans; Chromatography, High Pressure Liquid; Diagnosis, Differential; Disease Progression; Female; gamma-Tocopherol; Humans; Magnetic Resonance Imaging; Male; Prognosis; Reproducibility of Results; Severity of Illness Index; Tocotrienols; Vitamin E | 2013 |
Your best bets for preventing Alzheimer's disease.
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Diet; Exercise; Humans; Ibuprofen; Vitamin E | 2002 |
Plasma antioxidant activity and vascular dementia.
Topics: Aged; Alzheimer Disease; Antioxidants; Cholesterol; Chromatography, High Pressure Liquid; Dementia, Vascular; Female; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Vitamin E | 2002 |
Antioxidants and risk of Alzheimer disease.
Topics: Alzheimer Disease; Antioxidants; Diet; Dietary Supplements; Humans; Risk Factors; Silicon; Vitamin E | 2002 |
Antioxidants and risk of Alzheimer disease.
Topics: Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cyclooxygenase Inhibitors; Diet; Dietary Supplements; Humans; Vitamin E | 2002 |
Vitamin E and C supplements and risk of dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Ascorbic Acid; Cohort Studies; Dementia, Vascular; Dietary Supplements; Humans; Male; Oxidative Stress; Proportional Hazards Models; Risk; Vitamin E | 2002 |
Antioxidant vitamin intake and risk of Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Ascorbic Acid; Carotenoids; Cohort Studies; Diet; Dietary Supplements; Female; Humans; Incidence; Male; Risk Factors; Vitamin E | 2003 |
The role of free radicals in canine counterpart of senile dementia of the Alzheimer type.
Topics: Alzheimer Disease; Animals; Brain; Dog Diseases; Dogs; Erythrocytes; Free Radicals; Lipid Peroxidation; Lipofuscin; Oxidative Stress; Vitamin E | 2003 |
Diagnosis and management of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Cholinesterase Inhibitors; Female; Ginkgo biloba; Humans; Male; Memantine; Vitamin E | 2003 |
Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease.
Topics: Aging; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Antioxidants; Brain; Dietary Supplements; Disease Models, Animal; Disease Progression; Lipid Peroxidation; Mice; Mice, Transgenic; Oxidative Stress; Plaque, Amyloid; Time Factors; Vitamin E | 2004 |
Cytochrome c oxidase is decreased in Alzheimer's disease platelets.
Topics: Adenine Nucleotides; Adenosine Triphosphate; Age of Onset; Aged; Alzheimer Disease; Blood Platelets; Case-Control Studies; Cholesterol; Chromatography, High Pressure Liquid; Citrate (si)-Synthase; Electron Transport Complex I; Electron Transport Complex IV; Electrophoresis, Gel, Two-Dimensional; Free Radicals; Humans; Middle Aged; Mitochondria; NADP; Succinate Cytochrome c Oxidoreductase; Vitamin E | 2004 |
Ignoring the controversies: newspaper reports on Alzheimer's disease treatments.
Topics: Alzheimer Disease; Canada; Donepezil; Humans; Indans; Newspapers as Topic; Nootropic Agents; Piperidines; United Kingdom; United States; Vitamin E | 2003 |
Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study.
Topics: Aged; Alzheimer Disease; Antioxidants; Ascorbic Acid; Cross-Sectional Studies; Dietary Supplements; Female; Humans; Incidence; Male; Middle Aged; Prevalence; Prospective Studies; Risk Factors; Vitamin E | 2004 |
Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Ascorbic Acid; Ascorbic Acid Deficiency; Case-Control Studies; Dementia; Female; Geriatric Assessment; Humans; Male; Nutritional Status; Psychiatric Status Rating Scales; Vitamin E | 2004 |
Micronutrient supplementation in mild Alzheimer disease patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Body Mass Index; Cognition; Dietary Supplements; Energy Intake; Feeding and Eating Disorders; Female; Humans; Magnesium; Male; Memory; Micronutrients; Middle Aged; Nutritional Status; Selenium; Skinfold Thickness; Vitamin E; Zinc | 2004 |
More on vitamins and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Ascorbic Acid; Follow-Up Studies; Humans; Vitamin E | 2004 |
12/15-lipoxygenase is increased in Alzheimer's disease: possible involvement in brain oxidative stress.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Blotting, Western; Brain; Cerebellum; Female; Frontal Lobe; Humans; Hydrogen Peroxide; Immunohistochemistry; Lipid Peroxidation; Male; Middle Aged; Oxidants; Oxidative Stress; Oxygen; Temporal Lobe; Vitamin E | 2004 |
Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study.
Topics: Age Distribution; Aged; Aging; Alzheimer Disease; Antioxidants; Ascorbic Acid; Asian; beta Carotene; Dementia; Dementia, Vascular; Diet Surveys; Feeding Behavior; Flavonoids; Hawaii; Humans; Incidence; Longitudinal Studies; Male; Middle Aged; Risk Assessment; Smoking; Vitamin E | 2004 |
Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Astrocytes; Brain; Cells, Cultured; Ceramides; Enzyme Induction; Free Radicals; Gene Expression Regulation, Enzymologic; Glioma; Inflammation; Inflammation Mediators; Lipopolysaccharides; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Reactive Oxygen Species; Sphingomyelins; Transcription Factors; Vitamin E | 2004 |
Vitamin E in neurodegenerative diseases.
Topics: Aged; Alzheimer Disease; Developing Countries; Humans; Neurodegenerative Diseases; Vitamin E | 2004 |
Brain cholinesterases: III. Future perspectives of AD research and clinical practice.
Topics: Acetylcarnitine; Alzheimer Disease; Brain; Cholinesterases; Cytidine Diphosphate Choline; Enzyme Activators; Humans; Meclofenoxate; Selegiline; Vitamin E | 2004 |
Delaying Alzheimer's. In a new study, Aricept held it off for 18 months. Is this drug right for you?
Topics: Alzheimer Disease; Donepezil; Humans; Indans; Nootropic Agents; Piperidines; Placebos; Randomized Controlled Trials as Topic; Treatment Outcome; United States; Vitamin E | 2004 |
Canadian Outcomes Study in Dementia: study methods and patient characteristics.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Canada; Cholinesterase Inhibitors; Cluster Analysis; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; Drug Therapy; Drug Therapy, Combination; Female; Health Status; Humans; Male; Mental Health Services; Outcome Assessment, Health Care; Phytotherapy; Prospective Studies; Quality Assurance, Health Care; Sampling Studies; Severity of Illness Index; Vitamin E | 2004 |
Plasma levels of antioxidants are not associated with Alzheimer's disease or cognitive decline.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Cognition Disorders; Cohort Studies; Cross-Sectional Studies; Female; Geriatric Assessment; Humans; Logistic Models; Male; Mental Status Schedule; Netherlands; Odds Ratio; Population Surveillance; Prospective Studies; Statistics as Topic; Vitamin A; Vitamin E | 2005 |
I have been taking vitamin E to help prevent Alzheimer's but recently heard about adverse effects from taking this supplement. Should I stop my vitamin E?
Topics: Alzheimer Disease; Female; Humans; Mortality; Vitamin E | 2005 |
Mild cognitive impairment--no benefit from vitamin E, little from donepezil.
Topics: Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cholinesterase Inhibitors; Cognition Disorders; Disease Progression; Donepezil; Humans; Indans; Nootropic Agents; Piperidines; Treatment Failure; Vitamin E | 2005 |
Oxidative stress induced by beta-amyloid peptide(1-42) is involved in the altered composition of cellular membrane lipids and the decreased expression of nicotinic receptors in human SH-SY5Y neuroblastoma cells.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid beta-Peptides; Cholesterol; Dose-Response Relationship, Drug; Humans; Lipid Peroxidation; Membrane Lipids; Neurons; Oxidation-Reduction; Oxidative Stress; Peptide Fragments; Phospholipids; Receptors, Nicotinic; Tumor Cells, Cultured; Ubiquinone; Vitamin E | 2005 |
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients.
Topics: Aged; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Antioxidants; Apolipoproteins E; Ascorbic Acid; Case-Control Studies; Copper; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidation-Reduction; Polymorphism, Genetic; Severity of Illness Index; Thiobarbituric Acid Reactive Substances; Vitamin E | 2004 |
Drug may temporarily slow progression of mild cognitive impairment.
Topics: Alzheimer Disease; Cognition Disorders; Donepezil; Female; Humans; Indans; Nootropic Agents; Piperidines; Vitamin E | 2005 |
Nanosphere-mediated delivery of vitamin E increases its efficacy against oxidative stress resulting from exposure to amyloid beta.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Drug Delivery Systems; Humans; Nanotubes; Oxidative Stress; Reactive Oxygen Species; Vitamin E | 2005 |
Certain vitamins in food may lower your risk of Alzheimer's.
Topics: Alzheimer Disease; Antioxidants; Ascorbic Acid; Humans; Vitamin E | 2002 |
Vitamin E and donepezil for the treatment of mild cognitive impairment.
Topics: Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cholinesterase Inhibitors; Data Interpretation, Statistical; Disease Progression; Donepezil; Heterozygote; Humans; Indans; Piperidines; Vitamin E | 2005 |
Difficult times for Alzheimer's treatments.
Topics: Alzheimer Disease; Alzheimer Vaccines; Amyloid beta-Peptides; Antipsychotic Agents; Cholinesterase Inhibitors; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Vitamin E; Vitamins | 2005 |
A key role for the microglial NADPH oxidase in APP-dependent killing of neurons.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Antioxidants; Ascorbic Acid; Blotting, Western; Cell Count; Cell Culture Techniques; Cell Death; Cell Line, Tumor; Enzyme Inhibitors; Humans; Macrophages; Microglia; Microscopy, Fluorescence; Mutation; NADPH Oxidases; Neurons; Onium Compounds; Protease Nexins; Reactive Oxygen Species; Receptors, Cell Surface; Transduction, Genetic; Vitamin E | 2006 |
Functional Vitamin E deficiency in ApoE4 patients with Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoprotein E4; Apolipoproteins E; Cholesterol; Cohort Studies; Female; Humans; Male; Middle Aged; Oxidative Stress; Phenotype; Statistics as Topic; Vitamin E; Vitamin E Deficiency | 2006 |
Drug prescription in mild cognitive impairment: the physicians' perspective in Italy.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Cognition Disorders; Female; Ginkgo biloba; Humans; Italy; Male; Middle Aged; Nootropic Agents; Practice Patterns, Physicians'; Surveys and Questionnaires; Vitamin E; Vitamins | 2006 |
Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model.
Topics: Alzheimer Disease; Animals; Antioxidants; Disease Models, Animal; Ginkgo biloba; Mice; Mice, Transgenic; Microscopy, Fluorescence, Multiphoton; Neurites; Oxidative Stress; Plant Extracts; Plaque, Amyloid; Reactive Oxygen Species; Vitamin E | 2006 |
Oxidative stress mediates tau-induced neurodegeneration in Drosophila.
Topics: Alzheimer Disease; Animals; Disease Models, Animal; Drosophila; Humans; Nerve Degeneration; Oxidative Stress; Paraquat; tau Proteins; Tauopathies; Vitamin E | 2007 |
Antioxidants and Alzheimer's disease: time to stop feeding vitamin E to dementia patients?
Topics: Aging; Alzheimer Disease; Antioxidants; Cognition Disorders; Humans; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Oxidative Stress; Selegiline; Vitamin E | 2007 |
Swedish amyloid precursor protein mutation increases phosphorylation of eIF2alpha in vitro and in vivo.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Case-Control Studies; Cell Death; Cell Line; Cerebral Cortex; Eukaryotic Initiation Factor-2; Gene Expression Regulation; Humans; Immunohistochemistry; Matched-Pair Analysis; Mice; Mice, Transgenic; Mutation; Neurons; Phosphorylation; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Transfection; Vitamin E | 2007 |
Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Ascorbic Acid; Chromatography, High Pressure Liquid; Dementia, Vascular; Deoxyguanosine; DNA Damage; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; Neuropsychological Tests; Oxidative Stress; Uric Acid; Vitamin A; Vitamin E | 2008 |
Antioxidants and prevention of cognitive decline: does duration of use matter?
Topics: Alzheimer Disease; Antioxidants; beta Carotene; Clinical Trials as Topic; Cognition Disorders; Humans; Time Factors; Treatment Outcome; Vitamin E | 2007 |
Persistence of contradicted claims in the literature.
Topics: Alzheimer Disease; beta Carotene; Epidemiologic Studies; Estrogens; Evidence-Based Medicine; Humans; Neoplasms; Observation; Publication Bias; Randomized Controlled Trials as Topic; Vitamin E; Vitamins | 2007 |
Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Brain; Glutathione; Lipid Peroxidation; Mice; Mice, Transgenic; Oxidative Stress; Plaque, Amyloid; Vitamin E | 2008 |
Demential syndromes and the lipid metabolism.
Topics: Alzheimer Disease; Catalase; Central Nervous System; Dementia; Free Radicals; Glutathione Peroxidase; Humans; Lipid Metabolism; Lipofuscin; Selenium; Tissue Distribution; Vitamin E | 1984 |
17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro.
Topics: Aldosterone; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Animals; Antioxidants; beta-Galactosidase; Cell Death; Cell Line; Cell Survival; Cholesterol; Corticosterone; Estradiol; Glutamic Acid; Hippocampus; Humans; Hydrogen Peroxide; Luciferases; Mice; Neurons; Neurotoxins; Oxidative Stress; Progesterone; Receptors, Estrogen; Recombinant Fusion Proteins; Transfection; Vitamin E | 1995 |
No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Antiparkinson Agents; Brain; Cabergoline; Carbidopa; Diabetes Mellitus; Ergolines; Female; Free Radicals; Humans; Levodopa; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Parkinson Disease; Selegiline; Vitamin E | 1995 |
Treatment of Alzheimer's disease -- searching for a breakthrough, settling for less.
Topics: Alzheimer Disease; Confounding Factors, Epidemiologic; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Monoamine Oxidase Inhibitors; Outcome Assessment, Health Care; Selegiline; Vitamin E | 1997 |
Unidentified antioxidant defences of human plasma in immobilized patients: a possible relation to basic metabolic rate.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Ascorbic Acid; Basal Metabolism; Cerebrovascular Disorders; Female; Humans; Immobilization; Middle Aged; Sulfhydryl Compounds; Uric Acid; Vitamin E | 1997 |
Increased susceptibility of Alzheimer's disease temporal cortex to oxygen free radical-mediated processes.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Cerebellum; Free Radicals; Humans; In Vitro Techniques; Kinetics; Lipid Peroxidation; Luminescent Measurements; Middle Aged; Reactive Oxygen Species; Temporal Lobe; Thiobarbituric Acid Reactive Substances; Vitamin E | 1997 |
Study suggests antioxidants slow decline in Alzheimer's disease.
Topics: Alzheimer Disease; Antioxidants; Disease Progression; Humans; Selegiline; Vitamin E | 1997 |
Alpha-tocopherol and Alzheimer's disease.
Topics: Alzheimer Disease; Bias; Humans; Proportional Hazards Models; Selegiline; Survival Analysis; Vitamin E | 1997 |
Alpha-tocopherol and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cognition; Drug Therapy, Combination; Educational Status; Humans; Male; Selegiline; Vitamin E | 1997 |
Selegiline and vitamin E in Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Disease Progression; Drug Combinations; Humans; Neuroprotective Agents; Randomized Controlled Trials as Topic; Reproducibility of Results; Selegiline; Treatment Outcome; Vitamin E | 1997 |
Heme from Alzheimer's brain inhibits muscarinic receptor binding via thiyl radical generation.
Topics: Alzheimer Disease; Ascorbic Acid; Brain Chemistry; Estradiol; Free Radicals; Heme; Humans; In Vitro Techniques; Mass Spectrometry; Membranes; Muscarinic Antagonists; Receptors, Muscarinic; Sulfhydryl Compounds; Vitamin E | 1997 |
Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Case-Control Studies; Female; Humans; Linear Models; Lumbosacral Region; Male; Vitamin E | 1997 |
Vitamin E protects against Alzheimer's amyloid peptide (25-35)-induced changes in neocortical synaptosomal membrane lipid structure and composition.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Cerebral Cortex; Electron Spin Resonance Spectroscopy; Fatty Acids, Nonesterified; Gerbillinae; Lipid Peroxides; Male; Membrane Lipids; Peptide Fragments; Spin Labels; Stearates; Synaptosomes; Vitamin E | 1998 |
Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease.
Topics: Alzheimer Disease; Animals; Antioxidants; Ascorbic Acid; Brain; Cell Death; Cell Survival; Humans; Lipoproteins, LDL; Lipoproteins, VLDL; Neurons; Neuroprotective Agents; PC12 Cells; Rats; Vitamin E | 1998 |
Drug treatment for Alzheimer's disease.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Drug Therapy, Combination; Estrogen Replacement Therapy; Female; Humans; Indans; Male; Neuroprotective Agents; Piperidines; Selegiline; Vitamin E | 1998 |
Advances in the treatment of Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cholinesterase Inhibitors; Cognition; Controlled Clinical Trials as Topic; Humans; Neuroprotective Agents; Nootropic Agents; Selegiline; Tacrine; Vitamin E | 1998 |
Altered Ca2+ signaling and mitochondrial deficiencies in hippocampal neurons of trisomy 16 mice: a model of Down's syndrome.
Topics: Aging; Alzheimer Disease; Animals; Calcium; Carcinogens; Cell Death; Cyclosporine; Diploidy; Disease Models, Animal; Down Syndrome; Excitatory Amino Acid Antagonists; Female; Glutamic Acid; Hippocampus; Karyotyping; Male; Membrane Potentials; Mice; Mice, Neurologic Mutants; Mitochondria; NADP; Neurons; Potassium; Quinoxalines; Signal Transduction; Trisomy; Vitamin E | 1998 |
Alzheimer's disease management.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cholinesterase Inhibitors; Donepezil; Humans; Indans; Middle Aged; Piperidines; Selegiline; Tacrine; Vitamin E | 1998 |
Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Ascorbic Acid; Boston; Cross-Sectional Studies; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Male; Urban Population; Vitamin E | 1998 |
The free radical antioxidant vitamin E protects cortical synaptosomal membranes from amyloid beta-peptide(25-35) toxicity but not from hydroxynonenal toxicity: relevance to the free radical hypothesis of Alzheimer's disease.
Topics: Aldehydes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Biomarkers; Cells, Cultured; Cerebral Cortex; Electron Spin Resonance Spectroscopy; Free Radical Scavengers; Neuroprotective Agents; Oxidation-Reduction; Peptide Fragments; Rats; Rats, Sprague-Dawley; Synaptosomes; Tetrazolium Salts; Thiazoles; Vitamin E | 1998 |
Low plasma vitamin C in Alzheimer patients despite an adequate diet.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ascorbic Acid; Ascorbic Acid Deficiency; Female; France; Geriatric Assessment; Humans; Male; Mental Status Schedule; Middle Aged; Nutrition Assessment; Reference Values; Social Environment; Vitamin E | 1998 |
Protective effects of idebenone and alpha-tocopherol on beta-amyloid-(1-42)-induced learning and memory deficits in rats: implication of oxidative stress in beta-amyloid-induced neurotoxicity in vivo.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Avoidance Learning; Benzoquinones; Brain Chemistry; Drug Interactions; Injections, Intraventricular; Lipid Peroxidation; Locomotion; Male; Maze Learning; Memory; Nerve Degeneration; Neurotoxins; Oxidative Stress; Peptide Fragments; Rats; Rats, Wistar; Ubiquinone; Vitamin E | 1999 |
Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington.
Topics: Alzheimer Disease; Anti-Inflammatory Agents; Caregivers; Cholinesterase Inhibitors; Estrogens; Geriatrics; Humans; Primary Health Care; Vitamin E | 1999 |
Ask the doctor. In your article on Alzheimer's disease (March, 1999), you mention "high doses of vitamin E" as helpful in slowing the progression of the condition. Specifically, what dose is recommended?
Topics: Alzheimer Disease; Antioxidants; Disease Progression; Humans; Vitamin E | 1999 |
The antioxidant vitamin E modulates amyloid beta-peptide-induced creatine kinase activity inhibition and increased protein oxidation: implications for the free radical hypothesis of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cell Death; Cells, Cultured; Creatine Kinase; Electron Spin Resonance Spectroscopy; Embryo, Mammalian; Free Radicals; Hippocampus; Nerve Tissue Proteins; Neurons; Oxidation-Reduction; Oxidative Stress; Peptide Fragments; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Vitamin E | 1999 |
Vitamin E and other antioxidants in neuroprotection.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Estrogens; Female; Free Radical Scavengers; Haloperidol; Humans; Male; Nerve Degeneration; Neurodegenerative Diseases; Neurons; NF-kappa B; Oxidative Stress; Signal Transduction; Vitamin E | 1999 |
Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Analysis of Variance; Apolipoproteins E; Blood Platelets; Catechol O-Methyltransferase; Erythrocytes; Female; Genotype; Glutathione; Humans; Leukocytes; Male; Malondialdehyde; Middle Aged; Monoamine Oxidase; Oxidation-Reduction; Uric Acid; Vitamin E | 1999 |
To E or not to E: how much is the question.
Topics: Alzheimer Disease; Antioxidants; Female; Heart Diseases; Humans; Male; Parkinson Disease; Vitamin E | 1999 |
Susceptibility to beta-amyloid-induced toxicity is decreased in goto-kakizaki diabetic rats: involvement of oxidative stress.
Topics: Adenine Nucleotides; Alzheimer Disease; Amino Acids; Amyloid beta-Peptides; Animals; Blood Glucose; Brain Chemistry; Cerebral Cortex; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Hyperglycemia; Lipid Peroxidation; Male; Oxidation-Reduction; Oxidative Stress; Peptide Fragments; Rats; Rats, Mutant Strains; Rats, Wistar; Synaptosomes; Thiobarbituric Acid Reactive Substances; Vitamin E | 2000 |
Increased lipoprotein oxidation in Alzheimer's disease.
Topics: Age Factors; Aged; Alzheimer Disease; Apolipoproteins E; beta Carotene; Cholesterol; Fatty Acids, Nonesterified; Female; Genotype; Humans; Lipoproteins; Male; Middle Aged; Oxidation-Reduction; Reference Values; Smoking; Triglycerides; Vitamin E | 2000 |
Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
Topics: Algorithms; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Caregivers; Cholinesterase Inhibitors; Clinical Trials as Topic; Cost-Benefit Analysis; Donepezil; Drug Interactions; Estrogens; Female; Ginkgo biloba; Humans; Indans; Male; Managed Care Programs; Nootropic Agents; Patient Selection; Phytotherapy; Piperidines; Plants, Medicinal; Psychotropic Drugs; Quality of Health Care; Selegiline; Tacrine; Time Factors; Vitamin E | 2000 |
NT2 neurons, a classical model for Alzheimer's disease, are highly susceptible to oxidative stress.
Topics: Alzheimer Disease; Ascorbic Acid; Cell Death; Cell Differentiation; Drug Combinations; Fatty Acids; Ferrous Compounds; Humans; Hydrogen Peroxide; L-Lactate Dehydrogenase; Lipid Peroxides; Neurons; Oxidants; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Tumor Cells, Cultured; Vitamin E | 2000 |
Multiple mechanisms underlie neurotoxicity by different types of Alzheimer's disease mutations of amyloid precursor protein.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Base Sequence; Cell Death; DNA Primers; Humans; Mutagenesis, Site-Directed; Mutation; Neurons; Vitamin E | 2000 |
Epidemiologic clues to the causes and routes to prevention of Alzheimer disease.
Topics: Aging; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; Environment; Epidemiologic Methods; Histamine H2 Antagonists; Humans; Memory; Risk Factors; Vitamin E | 2000 |
Should we encourage the use of high-dose vitamin E in persons with memory complaints as a preventive strategy against Alzheimer's disease?
Topics: Alzheimer Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Male; Middle Aged; Vitamin E | 2000 |
Current and future treatments for cognitive deficits in dementia.
Topics: Aged; Alzheimer Disease; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Cholinergic Agents; Cholinesterase Inhibitors; Cognition Disorders; Estrogens; Forecasting; Ginkgo biloba; Humans; Mental Health Services; Phytotherapy; Plants, Medicinal; Vitamin E | 2000 |
Impact of apoE deficiency on oxidative insults and antioxidant levels in the brain.
Topics: Alzheimer Disease; Animals; Antioxidants; Apolipoproteins E; Frontal Lobe; Glutathione; Hippocampus; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Oxidative Stress; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 2001 |
Pacifichem 2000: Pacific chemists throw switches, strike at disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Caenorhabditis elegans; Cells, Cultured; Computing Methodologies; Electrochemistry; Electrodes; Free Radicals; Humans; Methionine; Neurons; Rats; Societies, Scientific; Vitamin E | 2001 |
Elevated vulnerability to oxidative stress-induced cell death and activation of caspase-3 by the Swedish amyloid precursor protein mutation.
Topics: Alzheimer Disease; Amino Acid Chloromethyl Ketones; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Anilides; Animals; Antioxidants; Apoptosis; Aspartic Acid Endopeptidases; Caspase 3; Caspases; Cysteine Proteinase Inhibitors; Endopeptidases; Enzyme Activation; Humans; Hydrogen Peroxide; Mutation; Nerve Tissue Proteins; Oligopeptides; Oxidative Stress; PC12 Cells; Peptides; Proteins; Rats; Sweden; Transfection; Vitamin E | 2001 |
Medical utility of apoe allele determination in assessing the need for antioxidant therapy.
Topics: Alleles; Alzheimer Disease; Antioxidants; Apolipoprotein E4; Apolipoproteins E; Cognition Disorders; Coronary Disease; Genetic Predisposition to Disease; Humans; Models, Biological; Models, Genetic; Postoperative Complications; Stroke; Vitamin E | 2001 |
Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antioxidants; Biomarkers; Case-Control Studies; Eating; Erythrocytes; Female; Geriatric Assessment; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Oxidative Stress; Superoxide Dismutase; Vitamin A; Vitamin E | 2001 |
Absolute kinetic characterization of 17-beta-estradiol as a radical-scavenging, antioxidant synergist.
Topics: Alzheimer Disease; Antioxidants; Ascorbic Acid; Dose-Response Relationship, Drug; Estradiol; Free Radical Scavengers; Kinetics; Models, Chemical; Phenol; Spectrophotometry; Vitamin E | 2001 |
[Alzheimer patients. To treat with anti-dementia drugs in spite of unanswered questions].
Topics: Alzheimer Disease; Antidepressive Agents; Brain; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Ginkgo biloba; Humans; Multicenter Studies as Topic; Phytotherapy; Placebos; Time Factors; Tomography, Emission-Computed; Vitamin E | 2001 |
[To differentiate Alzheimer's and vascular dementia? Today no longer up to date].
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Clinical Trials as Topic; Dementia, Vascular; Diagnosis, Differential; Ginkgo biloba; Humans; Phytotherapy; Placebos; Time Factors; Vitamin E | 2001 |
Ursolic acid of Origanum majorana L. reduces Abeta-induced oxidative injury.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Cell Death; Humans; Lamiaceae; Lipid Peroxidation; PC12 Cells; Rats; Reactive Oxygen Species; Triterpenes; Ursolic Acid; Vitamin E | 2002 |
Is vitamin E the magic bullet for the treatment of Alzheimer's disease (AD)?
Topics: Alzheimer Disease; Canada; Cognition; Dietary Supplements; Evidence-Based Medicine; Humans; Vitamin E | 2000 |
Dietary intake of antioxidants and risk of Alzheimer disease.
Topics: Aged; Alzheimer Disease; Antioxidants; Ascorbic Acid; beta Carotene; Dementia; Dietary Supplements; Female; Flavonoids; Humans; Male; Middle Aged; Nutrition Assessment; Oxidative Stress; Proportional Hazards Models; Prospective Studies; Risk; Vitamin E | 2002 |
Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study.
Topics: Aged; Alzheimer Disease; Antioxidants; Apolipoprotein E4; Apolipoproteins E; Ascorbic Acid; beta Carotene; Black People; Cluster Analysis; Dietary Supplements; Female; Humans; Male; Models, Statistical; Nutrition Assessment; Oxidative Stress; Prospective Studies; Risk; Vitamin E; White People | 2002 |
Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; beta Carotene; Carotenoids; Dementia, Multi-Infarct; Female; Free Radicals; Humans; Male; Reference Values; Vitamin A; Vitamin E | 1992 |
Serum aluminium and zinc and other variables in patients with and without cognitive impairment in the community.
Topics: Aged; Aluminum; Alzheimer Disease; Erythrocyte Membrane; Humans; Lipid Peroxidation; Vitamin E; Zinc | 1991 |
Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E.
Topics: Aged; Alzheimer Disease; Brain; Glutathione; Glutathione Disulfide; Humans; Parkinson Disease; Vitamin E | 1991 |
Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls.
Topics: Adult; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Down Syndrome; Fetus; Humans; Middle Aged; Vitamin E | 1989 |
Lipid peroxidation and free radical scavengers in Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Ascorbic Acid; Ceruloplasmin; Copper; Female; Free Radicals; Glutathione Peroxidase; Humans; Lipid Peroxidation; Male; Nutritional Status; Selenium; Serum Albumin; Superoxide Dismutase; Transferrin; Vitamin A; Vitamin E; Zinc | 1989 |
Vitamin E in brains of patients with Alzheimer's disease and Down's syndrome.
Topics: Aged; Alzheimer Disease; Brain Chemistry; Down Syndrome; Humans; Vitamin E | 1986 |
Vitamin E and Alzheimer's disease in subjects with Down's syndrome.
Topics: Adult; Alzheimer Disease; Down Syndrome; Female; Humans; Male; Middle Aged; Risk Factors; Vitamin E; Vitamin E Deficiency | 1988 |
[Recent topics on Alzheimer's disease. Alzheimer's disease from the viewpoint of the free radical theory].
Topics: Aging; Alzheimer Disease; Animals; Brain; Free Radicals; Humans; Lipid Peroxides; Vitamin E | 1988 |
[Biochemistry of the physiopathologic and clinical aspects of free radicals in cerebral degenerative diseases such as Alzheimer's and Parkinson diseases].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alzheimer Disease; Animals; Catecholamines; Free Radicals; Humans; Lipid Peroxides; Monoamine Oxidase; Parkinson Disease; Pyridines; Superoxide Dismutase; Vitamin E | 1988 |